var title_f36_29_37328="Gram stain sputum 3";
var content_f36_29_37328=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F82062&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F82062&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gram stain sputum 3",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 338px; height: 241px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_29_37328=[""].join("\n");
var outline_f36_29_37328=null;
var title_f36_29_37329="Anomalous pancreaticobiliary union long Y";
var content_f36_29_37329=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F65676&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F65676&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anomalous pancreaticobiliary union, long Y type",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 498px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic retrograde cholangiopancreatography (ERCP) showing an anomalous pancreaticobiliary union, type long \"Y\". There is no cystic dilatation of the common bile duct.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Guelrud M, Carr-Locke DL, Fox VL. ERCP in Pediatric Practice: Diagnosis and Treatment. Isis Medical Media, London 1997. Copyright &copy; 1997 Taylor and Francis.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_29_37329=[""].join("\n");
var outline_f36_29_37329=null;
var title_f36_29_37330="Elbow joint";
var content_f36_29_37330=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F66874&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F66874&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Elbow joint articulations",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 433px; height: 521px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The elbow is a complex hinge joint composed of three separate articulations: ulnohumeral (large purple circle), radiohumeral (small purple circle), and radioulnar (red circle). The radiohumeral and ulnohumeral articulations combine to provide hinge movement (purple arrows)and supination and pronation of the forearm is facilitated by pivoting at the radioulnar articulation (red arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_29_37330=[""].join("\n");
var outline_f36_29_37330=null;
var title_f36_29_37331="Patient information: Prenatal care (The Basics)";
var content_f36_29_37331=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/85727\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?7/20/7495\">",
"         Pregnancy terms",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?17/45/18131\">",
"          Different baby positions in the uterus",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?41/57/42897\">",
"         Patient information: Amniocentesis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?17/62/18402\">",
"         Patient information: Breech pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?38/46/39663\">",
"         Patient information: Chorionic villus sampling (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?11/46/12002\">",
"         Patient information: Gestational diabetes (diabetes that starts during pregnancy) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?37/1/37907\">",
"         Patient information: How to plan and prepare for a healthy pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?4/2/4131\">",
"         Patient information: How to tell when labor starts (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?12/13/12499\">",
"         Patient information: Labor and delivery (childbirth) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?40/59/41906\">",
"         Patient information: Nutrition before and during pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/53/28498\">",
"         Patient information: Preeclampsia (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?3/59/4019\">",
"         Patient information: Pregnancy in Rh-negative women (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?10/50/11043\">",
"         Patient information: Should I have a screening test for Down syndrome during pregnancy? (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?36/56/37762\">",
"         Patient information: Taking over-the-counter medicines during pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?14/28/14785\">",
"         Patient information: Amniocentesis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?2/7/2161\">",
"         Patient information: Chorionic villus sampling (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?39/58/40867\">",
"         Patient information: Preeclampsia (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?2/50/2851\">",
"         Patient information: Should I have a screening test for Down syndrome during pregnancy? (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Prenatal care (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H878802929\">",
"      <span class=\"h1\">",
"       What is prenatal care?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Prenatal care describes the medical care women get during their pregnancy. As part of your prenatal care, the doctor or midwife will:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Figure out when your baby is due",
"       </li>",
"       <li>",
"        Monitor your health to watch for problems",
"       </li>",
"       <li>",
"        Monitor your baby&rsquo;s health to check that he or she is growing well",
"       </li>",
"       <li>",
"        Talk with you about pregnancy, labor, and delivery, and make a plan for your labor and delivery",
"       </li>",
"       <li>",
"        Do tests to check you and your baby for different health conditions",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H878802944\">",
"      <span class=\"h1\">",
"       What happens at my first prenatal visit?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor or midwife will ask about your health and medical history, and figure out when your baby is due.",
"     </p>",
"     <p>",
"      He or she will also do an exam, including a speculum exam. For this, the doctor or midwife will place a metal or plastic device (called a speculum) in your vagina (",
"      <a class=\"graphic graphic_figure graphicRef82935 \" href=\"mobipreview.htm?7/20/7495\">",
"       figure 1",
"      </a>",
"      ). The speculum holds the walls of the vagina open. That way, the doctor or midwife can see the cervix. He or she will also put 1 hand on your belly and insert 1 or 2 gloved fingers of the other hand into the vagina. This is so your doctor or midwife can check your ovaries and the size of your uterus.",
"     </p>",
"     <p>",
"      He or she will also do tests that can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        A urine test",
"       </li>",
"       <li>",
"        Blood tests &ndash; Some blood tests check your general health. Other blood tests check for specific conditions that could cause problems for you or your baby.",
"       </li>",
"       <li>",
"        Lab tests on a sample of cells from the cervix &ndash; The doctor will use a cotton swab to take some cells from the cervix. He or she will test the sample for infections or cancer of the cervix.",
"       </li>",
"       <li>",
"        An ultrasound &ndash; An ultrasound uses sound waves to create pictures of the inside of your body and of your baby. This test is done to check your due date and see if you are pregnant with more than 1 baby.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H878802976\">",
"      <span class=\"h1\">",
"       What will happen at each prenatal visit?",
"      </span>",
"      &nbsp;&mdash;&nbsp;In the United States, at all prenatal visits (including the first visit), the doctor or midwife will:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Ask about your symptoms and answer any questions you have",
"       </li>",
"       <li>",
"        Check your blood pressure &ndash; Having high blood pressure can lead to problems, including a serious condition called &ldquo;preeclampsia.&rdquo;",
"       </li>",
"       <li>",
"        Check your weight &ndash; The amount of weight you should gain during pregnancy depends partly on what your weight was before you got pregnant.",
"       </li>",
"       <li>",
"        Measure the size of your uterus &ndash; Your uterus will get bigger as your pregnancy progresses.",
"       </li>",
"       <li>",
"        Listen for your baby&rsquo;s heartbeat &ndash; The doctor or midwife will be able to hear your baby&rsquo;s heartbeat starting at about 12 weeks of pregnancy.",
"       </li>",
"       <li>",
"        Test your urine to check for sugar or protein &ndash; Having sugar or protein in your urine might be a sign of a more serious problem.",
"       </li>",
"       <li>",
"        Ask about your baby&rsquo;s movements &ndash; Women start feeling their baby move at different times. Most women feel their baby move by 25 weeks of pregnancy.",
"       </li>",
"       <li>",
"        Check your baby&rsquo;s position in your uterus &ndash; In the last 3 months of pregnancy, the doctor or midwife will check your baby&rsquo;s position at each visit. He or she will check whether your baby&rsquo;s head or buttocks are down and closest to your vagina (",
"        <a class=\"graphic graphic_figure graphicRef72643 \" href=\"mobipreview.htm?17/45/18131\">",
"         figure 2",
"        </a>",
"        ).",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H878803014\">",
"      <span class=\"h1\">",
"       What other tests are part of prenatal care?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor or midwife will order other tests during your pregnancy. These include routine tests that all pregnant women will have. They also include tests that some women choose to have.",
"     </p>",
"     <p>",
"      Tests done during pregnancy can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        A test to check for diabetes (high blood sugar) &ndash; This involves drinking a sugar drink and then having your blood drawn.",
"       </li>",
"       <li>",
"        Blood tests to check for certain conditions or infections &ndash; These include tests to check your blood type and see if you have a condition called anemia. They also include tests to check for infections that you could pass to your baby or that could harm your baby. Some of these infections are rubella, hepatitis B, and syphilis.",
"       </li>",
"       <li>",
"        An ultrasound &ndash; This test checks your placenta, the fluid around your baby, how your baby is growing, and how your baby&rsquo;s organs are developing.",
"       </li>",
"       <li>",
"        Tests to check for birth defects or problems babies can be born with &ndash; For example, women can choose to test their baby for Down syndrome. Down syndrome is a life-long condition that causes medical and learning problems.",
"       </li>",
"       <li>",
"        Tests on your vaginal discharge (the fluid that leaks from your vagina) to check for an infection",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H878803029\">",
"      <span class=\"h1\">",
"       How often will I see my doctor or midwife during pregnancy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your visits to your doctor or midwife will get more frequent as your pregnancy progresses. One common schedule of visits is the following:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Every 4 weeks until you are about 28 weeks pregnant",
"       </li>",
"       <li>",
"        Then every 2 to 3 weeks until you are about 36 weeks pregnant",
"       </li>",
"       <li>",
"        Then every week until delivery",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Women with certain medical conditions (including conditions they had before they got pregnant) might need to see their doctor or midwife more often. They might also need other tests to follow their medical condition during pregnancy.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H878803044\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/53/28498?source=see_link\">",
"       Patient information: Preeclampsia (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/56/37762?source=see_link\">",
"       Patient information: Taking over-the-counter medicines during pregnancy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/46/12002?source=see_link\">",
"       Patient information: Gestational diabetes (diabetes that starts during pregnancy) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?40/59/41906?source=see_link\">",
"       Patient information: Nutrition before and during pregnancy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/1/37907?source=see_link\">",
"       Patient information: How to plan and prepare for a healthy pregnancy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?4/2/4131?source=see_link\">",
"       Patient information: How to tell when labor starts (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?10/50/11043?source=see_link\">",
"       Patient information: Should I have a screening test for Down syndrome during pregnancy? (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?38/46/39663?source=see_link\">",
"       Patient information: Chorionic villus sampling (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?41/57/42897?source=see_link\">",
"       Patient information: Amniocentesis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/13/12499?source=see_link\">",
"       Patient information: Labor and delivery (childbirth) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?17/62/18402?source=see_link\">",
"       Patient information: Breech pregnancy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/59/4019?source=see_link\">",
"       Patient information: Pregnancy in Rh-negative women (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/58/40867?source=see_link\">",
"       Patient information: Preeclampsia (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/7/2161?source=see_link\">",
"       Patient information: Chorionic villus sampling (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/50/2851?source=see_link\">",
"       Patient information: Should I have a screening test for Down syndrome during pregnancy? (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?14/28/14785?source=see_link\">",
"       Patient information: Amniocentesis (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?36/29/37331?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 85727 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-CC23815824-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_29_37331=[""].join("\n");
var outline_f36_29_37331=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H878802929\">",
"      What is prenatal care?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H878802944\">",
"      What happens at my first prenatal visit?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H878802976\">",
"      What will happen at each prenatal visit?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H878803014\">",
"      What other tests are part of prenatal care?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H878803029\">",
"      How often will I see my doctor or midwife during pregnancy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H878803044\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/85727\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?7/20/7495\">",
"      Pregnancy terms",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?17/45/18131\">",
"       Different baby positions in the uterus",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?14/28/14785?source=related_link\">",
"      Patient information: Amniocentesis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?41/57/42897?source=related_link\">",
"      Patient information: Amniocentesis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?17/62/18402?source=related_link\">",
"      Patient information: Breech pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/7/2161?source=related_link\">",
"      Patient information: Chorionic villus sampling (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?38/46/39663?source=related_link\">",
"      Patient information: Chorionic villus sampling (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/46/12002?source=related_link\">",
"      Patient information: Gestational diabetes (diabetes that starts during pregnancy) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/1/37907?source=related_link\">",
"      Patient information: How to plan and prepare for a healthy pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?4/2/4131?source=related_link\">",
"      Patient information: How to tell when labor starts (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/13/12499?source=related_link\">",
"      Patient information: Labor and delivery (childbirth) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?40/59/41906?source=related_link\">",
"      Patient information: Nutrition before and during pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/58/40867?source=related_link\">",
"      Patient information: Preeclampsia (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/53/28498?source=related_link\">",
"      Patient information: Preeclampsia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/59/4019?source=related_link\">",
"      Patient information: Pregnancy in Rh-negative women (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/50/2851?source=related_link\">",
"      Patient information: Should I have a screening test for Down syndrome during pregnancy? (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?10/50/11043?source=related_link\">",
"      Patient information: Should I have a screening test for Down syndrome during pregnancy? (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/56/37762?source=related_link\">",
"      Patient information: Taking over-the-counter medicines during pregnancy (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_29_37332="Clue cells";
var content_f36_29_37332=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F73248&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F73248&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Clue cells",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 366px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of clue cells observed in a patient with bacterial vaginosis. Note the obliteration of each epithelial cell margin by adherent G. vaginalis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jack D Sobel, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_29_37332=[""].join("\n");
var outline_f36_29_37332=null;
var title_f36_29_37333="Hemochromatosis - low power";
var content_f36_29_37333=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F62470&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F62470&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hemochromatosis (low power, Masson trichrome)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 251px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    There are multiple nodules and many bile ducts in the greatly enlarged portal triads. The liver is clearly cirrhotic.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_29_37333=[""].join("\n");
var outline_f36_29_37333=null;
var title_f36_29_37334="Management of refractory nonmalignant pleural effusions";
var content_f36_29_37334=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of refractory nonmalignant pleural effusions",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/29/37334/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/29/37334/contributors\">",
"     Peter Doelken, MD, FCCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/29/37334/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/29/37334/contributors\">",
"     Steven A Sahn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/29/37334/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/29/37334/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/29/37334/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 14, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary treatment of a nonmalignant pleural effusion (NMPE) should target the underlying cause of the effusion. Sometimes, nonmalignant effusions persist or recur despite appropriate treatment of the primary process. In this situation, symptomatic pleural effusions are usually treated with intermittent thoracentesis or pleurodesis; other options include placement of an indwelling pleural catheter for intermittent drainage, pleurectomy, or a pleural-peritoneal shunt.",
"   </p>",
"   <p>",
"    In this topic review, strategies for management of refractory nonmalignant pleural effusions are discussed. A diagnostic approach to pleural effusions is provided separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/7/16505?source=see_link\">",
"     \"Diagnostic evaluation of a pleural effusion in adults: Initial testing\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2632?source=see_link\">",
"     \"Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Options for primary treatment of malignant pleural effusions and specific types of nonmalignant pleural effusion are discussed within those topic reviews. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/6/13416?source=see_link\">",
"     \"Management of malignant pleural effusions\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/20/37192?source=see_link\">",
"     \"Etiology, clinical presentation, and diagnosis of chylothorax\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28089?source=see_link\">",
"     \"Parapneumonic effusion and empyema in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/21/16728?source=see_link\">",
"     \"Pleural effusions following cardiac surgery\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/27/23993?source=see_link\">",
"     \"Pleural effusions in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/47/22261?source=see_link\">",
"     \"Tuberculous pleural effusions in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/35/12856?source=see_link\">",
"     \"Tuberculous pleural effusions in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/62/4072?source=see_link\">",
"     \"Diagnosis and management of pleural causes of unexpandable lung\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/35/30263?source=see_link\">",
"     \"Hepatic hydrothorax\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary treatment is directed at the underlying cause of the pleural effusion in all patients with nonmalignant pleural effusions (",
"    <a class=\"graphic graphic_table graphicRef73530 \" href=\"mobipreview.htm?38/49/39708\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef54055 \" href=\"mobipreview.htm?37/9/38045\">",
"     table 2",
"    </a>",
"    ). Patients who have symptoms due to a pleural effusion that is refractory to primary treatment are candidates for additional therapies. Dyspnea is the most common symptom that necessitates additional therapy.",
"   </p>",
"   <p>",
"    Prior to proceeding with more invasive therapy, the underlying cause of the NMPE should be reconfirmed and trapped lung excluded. Trapped lung refers to development of a fibrous pleural peel that encases the visceral pleura while the visceral and parietal pleura are widely separated. This may occur after an underlying inflammatory condition of the pleura has been successfully treated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/62/4072?source=see_link&amp;anchor=H7#H7\">",
"     \"Diagnosis and management of pleural causes of unexpandable lung\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Asymptomatic patients do NOT require additional therapeutic intervention, as they may reach a steady state of pleural fluid volume and never become symptomatic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TREATMENT OPTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptomatic nonmalignant pleural effusions that are refractory to primary treatment are typically managed with repeated therapeutic thoracentesis or, for those with frequent recurrences, pleurodesis. Options other than pleurodesis for recurrent effusions include placement of an indwelling pleural catheter for intermittent drainage, pleurectomy, or a pleural-peritoneal shunt. Unfortunately, there is little scientific data to guide the clinician when choosing among these options.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Repeat thoracentesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Repeat therapeutic thoracentesis is a simple approach to managing a nonmalignant pleural effusion and is appropriate when the effusion reaccumulates slowly enough that repeat procedures do not become burdensome to the patient. In general, if thoracentesis for symptomatic relief is required more often than once a month, more definitive treatments should be considered (see below).",
"   </p>",
"   <p>",
"    The technique is largely similar to that used for diagnostic thoracentesis. Briefly, topical analgesia is administered and then under sterile conditions a needle is percutaneously advanced between the ribs, \"walking\" the needle up and over the superior margin of the chosen rib, and into the pleural space. A large volume of pleural fluid (eg, 1 to 1.5 L) is then drained. The procedure can be performed at the bedside or in an office setting with appropriate monitoring. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/23/12663?source=see_link&amp;anchor=H4#H4\">",
"     \"Diagnostic thoracentesis\", section on 'Technique'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Reexpansion pulmonary edema is a potential complication of therapeutic thoracentesis; however, it is uncommon and generally can be avoided by terminating the procedure if the patient develops anterior chest pain or the pleural pressure drops below -20 cm H2O [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/1\">",
"     1",
"    </a>",
"    ]. A threshold rate of pleural fluid removal below which reexpansion pulmonary edema is unlikely to occur has not been identified [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients may occasionally develop a drainage-related pneumothorax if the underlying lung cannot reexpand, as with entrapped lung or endobronchial obstruction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/2\">",
"     2",
"    </a>",
"    ]. Other complications of therapeutic thoracentesis are the same as those for diagnostic thoracentesis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/23/12663?source=see_link&amp;anchor=H10#H10\">",
"     \"Diagnostic thoracentesis\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapeutic thoracentesis is not beneficial to patients with pleural effusion due to trapped lung unless another cause for pleural fluid accumulation coexists. Dyspnea usually will not be relieved and the pleural effusion will rapidly reaccumulate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/62/4072?source=see_link\">",
"     \"Diagnosis and management of pleural causes of unexpandable lung\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pleurodesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pleurodesis is a procedure that obliterates the pleural space to prevent a recurrent pleural effusion following pleural drainage. After draining the effusion, a chemical irritant that induces inflammation and fibrosis is instilled into the pleural space (ie, chemical pleurodesis).",
"   </p>",
"   <p>",
"    Chemical pleurodesis, including indications, predictors of success, choice of chemical irritant, procedure, and complications, is discussed in detail separately. Among pleural sclerosants, talc has been most studied; however, head-to-head comparisons with other agents have not been performed in nonmalignant pleural effusions (NMPE). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/24/36232?source=see_link\">",
"     \"Chemical pleurodesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30615?source=see_link\">",
"     \"Talc pleurodesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We suggest that chemical pleurodesis be used for most symptomatic patients with NMPE whose pleural fluid reaccumulates over the course of days rather than weeks. For these patients, repeat therapeutic thoracentesis is likely to be inadequate. Although scientific studies are lacking, the evidence in favor of chemical pleurodesis for NMPE is outlined in the following sections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several types of nonmalignant pleural effusion (NMPE) have been successfully managed by pleurodesis, including those due to chronic ambulatory peritoneal dialysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/4-7\">",
"     4-7",
"    </a>",
"    ], yellow nail syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/8,9\">",
"     8,9",
"    </a>",
"    ], chylothorax [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/10-13\">",
"     10-13",
"    </a>",
"    ], nephrotic syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/14\">",
"     14",
"    </a>",
"    ], lupus pleuritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/13\">",
"     13",
"    </a>",
"    ], and heart failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. We avoid chemical pleurodesis in patients with hepatic hydrothorax, because of high recurrence rates. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Hepatic hydrothorax'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Chemical pleurodesis appears to be effective at managing most NMPE, based on data from several case series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/4-14,18-20\">",
"     4-14,18-20",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 68 patients, who underwent",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/39/28274?source=see_link\">",
"       talc pleurodesis",
"      </a>",
"      for NMPE, successful pleurodesis was observed in 47 (77 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/20\">",
"       20",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      In a series of 24 patients with NMPE, 80 percent of the effusions did not recur after chemical pleurodesis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/18\">",
"       18",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Another series of 16 patients with nonmalignant effusions, treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/39/28274?source=see_link\">",
"       talc pleurodesis",
"      </a>",
"      , reported complete success in 12 (75 percent) and partial success in another 3 (19 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/19\">",
"       19",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Two patients treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2714?source=see_link\">",
"       doxycycline",
"      </a>",
"      1 g intrapleurally had a complete response, although the standard dose for pleurodesis in malignant pleural effusion is 500 mg [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/21\">",
"       21",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pleurodesis is certain to fail in patients whose lungs do not fully reexpand (eg, trapped lung, lung entrapment, or endobronchial obstruction) because successful pleurodesis requires contact of the visceral and parietal pleura. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/62/4072?source=see_link\">",
"     \"Diagnosis and management of pleural causes of unexpandable lung\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, recurrent or persistent pleural effusion due to infection should prompt reevaluation of the diagnosis and primary therapy, NOT pleurodesis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28089?source=see_link\">",
"     \"Parapneumonic effusion and empyema in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/27/23993?source=see_link\">",
"     \"Pleural effusions in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/47/22261?source=see_link\">",
"     \"Tuberculous pleural effusions in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/35/12856?source=see_link\">",
"     \"Tuberculous pleural effusions in HIV-negative patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common adverse sequelae of chemical pleurodesis are fever, pain, and gastrointestinal symptoms (",
"    <a class=\"graphic graphic_table graphicRef51628 \" href=\"mobipreview.htm?36/30/37355\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef64436 \" href=\"mobipreview.htm?21/17/21788\">",
"     table 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/21\">",
"     21",
"    </a>",
"    ]. Far less commonly, patients may experience respiratory failure, cardiovascular complications, a systemic inflammatory response, empyema, decreased lung volume, and dissemination of the chemical agent. Although most complications have been reported in patients with a malignant pleural effusion, there is no reason to expect that complications will differ in patients with nonmalignant pleural effusions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/24/36232?source=see_link&amp;anchor=H16#H16\">",
"     \"Chemical pleurodesis\", section on 'Complications'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30615?source=see_link\">",
"     \"Talc pleurodesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Controversy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians have been concerned about exposing patients with nonmalignant disease to uncommon but potentially severe adverse sequelae related to chemical pleurodesis, particularly with talc [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. In particular, the immediate risks of respiratory failure after",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/39/28274?source=see_link\">",
"     talc pleurodesis",
"    </a>",
"    and the theoretic long-term risks of pleural calcification or malignancy have been discussed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. The risk of respiratory failure appears minimal when safeguards are followed, such as limiting the total dose to less than 5 g, using size-calibrated talc (eg, less than 10 percent of particles less than 5 to 10 microns), NOT combining talc pleurodesis with pleural abrasion, and NOT performing bilateral talc pleurodesis at one sitting. Medical talc does not contain asbestos and mesothelioma has not been reported. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30615?source=see_link\">",
"     \"Talc pleurodesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other options",
"    </span>",
"    &nbsp;&mdash;&nbsp;Additional management options for patients with nonmalignant pleural effusions include placing an indwelling pleural catheter for intermittent external drainage, pleuroperitoneal or pleurovenous shunts for internal drainage, or surgical pleurectomy. Experience with these techniques has been limited in patients with nonmalignant pleural effusions. However, the following observations may be helpful:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Indwelling catheter drainage has the disadvantages of ongoing protein losses and increased risk of infection, due to the greater frequency of external drainage afforded by this means of access. Based on these side effects, indwelling catheter drainage is not usually used for treatment of nonmalignant effusions. However, intermittent external drainage via an implanted pleural drainage catheter remains a treatment option in select patients who are not candidates for pleurodesis.",
"     </li>",
"     <li>",
"      A case series reported successful palliation of refractory nonmalignant effusions with placement of a pleuroperitoneal shunt [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/25\">",
"       25",
"      </a>",
"      ]. Twelve patients with benign effusions were included. Pleural empyema is a potential side effect [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Pleurovenous shunting has been evaluated in a case series [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/26\">",
"       26",
"      </a>",
"      ]. In one study, among 12 patients who had a pleurovenous shunt placed had successful palliation; however, one patient had a shunt occlusion and another had an early but unrelated death.",
"     </li>",
"     <li>",
"      Pleurectomy is generally reserved for patients whose pleural effusion is recurrent despite pleurodesis by less invasive means.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A more detailed discussion of these techniques is provided separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/6/13416?source=see_link\">",
"     \"Management of malignant pleural effusions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     HEPATIC HYDROTHORAX",
"    </span>",
"    &nbsp;&mdash;&nbsp;In our experience, hepatic hydrothorax is the most difficult form of NMPE to treat with chemical pleurodesis, although some successful results have been reported. In these patients, ascitic fluid moves rapidly through diaphragmatic defects into the pleural space, due to the pressure difference across the diaphragm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37334/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. As a result, it is often difficult to keep the two pleural surfaces apposed long enough for the inflammatory process to result in pleural symphysis.",
"   </p>",
"   <p>",
"    A management algorithm for hepatic hydrothorax is provided separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/35/30263?source=see_link\">",
"     \"Hepatic hydrothorax\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/50/10018?source=see_link\">",
"       \"Patient information: Pleural effusion (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary treatment of nonmalignant pleural effusions is directed at the underlying cause of the pleural effusion in all patients. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who have symptoms due to recurrent or persistent pleural effusion despite therapy directed at the underlying cause are candidates for additional therapies. Asymptomatic patients do not require additional interventions. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prior to proceeding with more invasive therapy, the underlying cause of the NMPE should be reconfirmed to ensure that primary treatment has been appropriate; infectious causes, hepatic hydrothorax, and trapped lung should also be excluded. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest repeat therapeutic thoracentesis for patients who have symptoms due to refractory nonmalignant pleural effusions (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Repeat thoracentesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest chemical pleurodesis talc for patients who have symptoms due to refractory nonmalignant pleural effusions and in whom repeat therapeutic thoracenteses have become burdensome (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The greatest pleurodesis experience is with talc; however, this choice is controversial due to concerns about immediate and long-term side effects of talc. To improve safety, size-calibrated talc is used in a total dose of 5 gm or less. Pleurodesis with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?2/41/2714?source=see_link\">",
"       doxycycline",
"      </a>",
"      would be a reasonable alternative. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Pleurodesis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30615?source=see_link\">",
"       \"Talc pleurodesis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In the absence of studies examining their efficacy, we do not routinely use indwelling pleural catheters, pleurectomy, or pleuroperitoneal shunts for nonmalignant pleural effusions. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Other options'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/1\">",
"      Doelken P, Huggins JT, Pastis NJ, Sahn SA. Pleural manometry: technique and clinical implications. Chest 2004; 126:1764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/2\">",
"      Heidecker J, Huggins JT, Sahn SA, Doelken P. Pathophysiology of pneumothorax following ultrasound-guided thoracentesis. Chest 2006; 130:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/3\">",
"      Huggins JT, Sahn SA, Heidecker J, et al. Characteristics of trapped lung: pleural fluid analysis, manometry, and air-contrast chest CT. Chest 2007; 131:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/4\">",
"      Benz RL, Schleifer CR. Hydrothorax in continuous ambulatory peritoneal dialysis: successful treatment with intrapleural tetracycline and a review of the literature. Am J Kidney Dis 1985; 5:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/5\">",
"      Simmons LE, Mir AR. A review of management of pleuroperitoneal communication in five CAPD patients. Adv Perit Dial 1989; 5:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/6\">",
"      Rodriguez-Perez, JC, Palop, L, Plaza, C, et al. Diagnosis and treatment of massive hydrothorax in CAPD. Perit Dial Bull 1984; 4:S49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/7\">",
"      Posen, G, Sachs, H. Treatment of recurrent pleural effusion in dialysis patients by talc insufflation (abstract). Trans Am Soc Artif Intern Organs 1979; 8:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/8\">",
"      Nordkild P, Kromann-Andersen H, Struve-Christensen E. Yellow nail syndrome--the triad of yellow nails, lymphedema and pleural effusions. A review of the literature and a case report. Acta Med Scand 1986; 219:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/9\">",
"      Hiller E, Rosenow EC 3rd, Olsen AM. Pulmonary manifestations of the yellow nail syndrome. Chest 1972; 61:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/10\">",
"      Adler RH, Levinsky L. Persistent chylothorax. Treatment by talc pleurodesis. J Thorac Cardiovasc Surg 1978; 76:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/11\">",
"      Lieberman J, Agliozzo CM. Intrapleural nitrogen mustard for treating chylous effusion of pulmonary lymphangioleiomyomatosis. Cancer 1974; 33:1505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/12\">",
"      Weissberg D. Talc pleurodesis : a controversial issue. Poumon Coeur 1981; 37:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/13\">",
"      Vargas FS, Milanez JR, Filomeno LT, et al. Intrapleural talc for the prevention of recurrence in benign or undiagnosed pleural effusions. Chest 1994; 106:1771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/14\">",
"      Jenkins PG, Shelp WD. Recurrent pleural transudate in the nephrotic syndrome. A new approach to treatment. JAMA 1974; 230:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/15\">",
"      Spicer AJ, Fisher JA. Recurring pleural effusion in congestive heart failure treated by pleurodesis. J Ir Med Assoc 1969; 62:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/16\">",
"      Davidoff D, Naparstek Y, Eliakim M. The use of pleurodesis for intractable pleural effusion due to congestive heart failure. Postgrad Med J 1983; 59:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/17\">",
"      Audier M, Boutin C, Arnaud A, D'Journo J. [Case of cardiac effusion treated by pleuroscopic talc spray]. Mars Med 1967; 104:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/18\">",
"      Sudduth CD, Sahn SA. Pleurodesis for nonmalignant pleural effusions. Recommendations. Chest 1992; 102:1855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/19\">",
"      Glazer M, Berkman N, Lafair JS, Kramer MR. Successful talc slurry pleurodesis in patients with nonmalignant pleural effusion. Chest 2000; 117:1404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/20\">",
"      Steger V, Mika U, Toomes H, et al. Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses. Ann Thorac Surg 2007; 83:1940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/21\">",
"      Herrington JD, Gora-Harper ML, Salley RK. Chemical pleurodesis with doxycycline 1 g. Pharmacotherapy 1996; 16:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/22\">",
"      Light RW. Talc should not be used for pleurodesis. Am J Respir Crit Care Med 2000; 162:2024.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/23\">",
"      Ghio AJ, Roggli V, Light RW. Talc should not be used for pleurodesis in patients with nonmalignant pleural effusions. Am J Respir Crit Care Med 2001; 164:1741; author reply 1741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/24\">",
"      Sahn SA. Talc should be used for pleurodesis. Am J Respir Crit Care Med 2000; 162:2023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/25\">",
"      Schneider T, Reimer P, Storz K, et al. Recurrent pleural effusion: who benefits from a tunneled pleural catheter? Thorac Cardiovasc Surg 2009; 57:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/26\">",
"      Artemiou O, Marta GM, Klepetko W, et al. Pleurovenous shunting in the treatment of nonmalignant pleural effusion. Ann Thorac Surg 2003; 76:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/27\">",
"      Temes RT, Davis MS, Follis FM, et al. Videothoracoscopic treatment of hepatic hydrothorax. Ann Thorac Surg 1997; 64:1468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/28\">",
"      Mouroux J, Perrin C, Venissac N, et al. Management of pleural effusion of cirrhotic origin. Chest 1996; 109:1093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37334/abstract/29\">",
"      Runyon BA, Greenblatt M, Ming RH. Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol 1986; 81:566.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6694 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-210.101.131.232-9B44C2D3FB-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_29_37334=[""].join("\n");
var outline_f36_29_37334=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TREATMENT OPTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Repeat thoracentesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Contraindications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pleurodesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Efficacy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Contraindications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Controversy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other options",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      HEPATIC HYDROTHORAX",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/6694\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6694|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/49/39708\" title=\"table 1\">",
"      Transudative pleural effusions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?37/9/38045\" title=\"table 2\">",
"      Exudative pleural effusions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?36/30/37355\" title=\"table 3\">",
"      Pleurodesis agents I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?21/17/21788\" title=\"table 4\">",
"      Pleurodesis agents II",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/24/36232?source=related_link\">",
"      Chemical pleurodesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/62/4072?source=related_link\">",
"      Diagnosis and management of pleural causes of unexpandable lung",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/7/16505?source=related_link\">",
"      Diagnostic evaluation of a pleural effusion in adults: Initial testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2632?source=related_link\">",
"      Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/23/12663?source=related_link\">",
"      Diagnostic thoracentesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/20/37192?source=related_link\">",
"      Etiology, clinical presentation, and diagnosis of chylothorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/35/30263?source=related_link\">",
"      Hepatic hydrothorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/6/13416?source=related_link\">",
"      Management of malignant pleural effusions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28089?source=related_link\">",
"      Parapneumonic effusion and empyema in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/50/10018?source=related_link\">",
"      Patient information: Pleural effusion (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/21/16728?source=related_link\">",
"      Pleural effusions following cardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/27/23993?source=related_link\">",
"      Pleural effusions in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30615?source=related_link\">",
"      Talc pleurodesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/47/22261?source=related_link\">",
"      Tuberculous pleural effusions in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/35/12856?source=related_link\">",
"      Tuberculous pleural effusions in HIV-negative patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_29_37335="Demarcation membrane system EM";
var content_f36_29_37335=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F81336&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F81336&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Megakaryocyte demarcation membrane",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 413px; height: 246px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transmission electron micrograph of a mature megakaryocyte shows prominent proliferation of a surface-connected demarcation membrane system (thin arrow) which has sequestered the cytoplasm into platelet-sized subunits (thick arrow). This membrane will later serve to provide the surface membrane for many platelets.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: White, JG. Delivery of Platelets from Megakaryocytes. In: Molecular Biology and Differentiation of Megakaryocytes, Breton-Gorius, J, Levin, J, Nurden, AT, Williams, N (Eds) Copyright &copy; 1990 John Wiley &amp;Sons, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_29_37335=[""].join("\n");
var outline_f36_29_37335=null;
var title_f36_29_37336="Trandolapril and verapamil: Drug information";
var content_f36_29_37336=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Trandolapril and verapamil: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?16/47/17141?source=see_link\">",
"    see \"Trandolapril and verapamil: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708901\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F229930\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Tarka&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F229931\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Tarka&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F229946\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Angiotensin-Converting Enzyme (ACE) Inhibitor;",
"     </li>",
"     <li>",
"      Calcium Channel Blocker",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F229932\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Hypertension:",
"     </b>",
"     Oral: Individualize dose. Patients receiving trandolapril (up to 8 mg) and verapamil (up to 240 mg) in separate tablets may wish to receive Tarka&reg; at equivalent dosages once daily.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F229933\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to dosing in individual monographs.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F229934\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Usual regimen need not be adjusted unless patient's creatinine clearance is &lt;30 mL/minute. Titration of individual components must be done prior to switching to combination product",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F229935\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Has not been evaluated in hepatic impairment. Verapamil is hepatically metabolized, adjustment of dosage in hepatic impairment is recommended.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F229921\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet, variable release: Trandolapril 2 mg [immediate release] and verapamil hydrochloride 180 mg [sustained release]; Trandolapril 2 mg [immediate release] and verapamil hydrochloride 240 mg [sustained release]; Trandolapril 4 mg [immediate release] and verapamil hydrochloride 240 mg [sustained release]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tarka&reg;:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     1/240: Trandolapril 1 mg [immediate release] and verapamil hydrochloride 240 mg [sustained release]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     2/180: Trandolapril 2 mg [immediate release] and verapamil hydrochloride 180 mg [sustained release]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     2/240: Trandolapril 2 mg [immediate release] and verapamil hydrochloride 240 mg [sustained release]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     4/240: Trandolapril 4 mg [immediate release] and verapamil hydrochloride 240 mg [sustained release]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F229911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F229923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of hypertension; however, not indicated for initial treatment of hypertension",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F229944\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F6363258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to trandolapril, verapamil, or other ACE inhibitors, or any other component of the formulation; severe left ventricular dysfunction; hypotension (systolic blood pressure &lt;90 mm Hg); cardiogenic shock; sick sinus syndrome (except in patients with a functioning pacemaker); second- or third-degree heart block (except in patients with a functioning pacemaker);atrial fibrillation or atrial flutter with an accessory bypass tract (eg, Wolff-Parkinson-White, Lown-Ganong-Levine syndromes); history of angioedema related to previous treatment with an ACE inhibitor; concomitant use with aliskiren in patients with diabetes mellitus",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F2529361\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Angioedema: At any time during treatment (especially following first dose) angioedema may occur rarely with ACE inhibitors; it may involve the head and neck (potentially compromising the airway) or the intestine (presenting with abdominal pain). African-Americans and patients with idiopathic or hereditary angioedema may be at an increased risk. Prolonged frequent monitoring may be required especially if tongue, glottis, or larynx are involved as they are associated with airway obstruction. Patients with a history of airway surgery may have a higher risk of airway obstruction. Aggressive early and appropriate management is critical. Use in patients with previous angioedema associated with ACE inhibitor therapy is contraindicated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cholestatic jaundice: A rare toxicity associated with ACE inhibitors includes cholestatic jaundice, which may progress to fulminant hepatic necrosis; discontinue if marked elevation of hepatic transaminases or jaundice occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Conduction abnormalities: Verapamil can cause first-degree AV block or sinus bradycardia; other conduction abnormalities are rare. Unless patients have a functioning pacemaker, contraindicated with sick sinus syndrome or second- or third-degree degree heart block.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cough: An ACE inhibitor cough is a dry, hacking, nonproductive one that usually occurs within the first few months of treatment and should generally resolve within 1-4 weeks after discontinuation of the ACE inhibitor. Other causes of cough should be considered (eg, pulmonary congestion in patients with heart failure) and excluded prior to discontinuation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperkalemia: May occur with ACE inhibitors; risk factors include renal dysfunction, diabetes mellitus, concomitant use of potassium-sparing diuretics, potassium supplements, and/or potassium-containing salts.  Use cautiously, if at all, with these agents and monitor potassium closely.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypersensitivity reactions: Anaphylactic/anaphylactoid reactions can occur with ACE inhibitors. Severe anaphylactoid reactions may be seen during hemodialysis (eg, CVVHD) with high-flux dialysis membranes (eg, AN69), and rarely, during low density lipoprotein apheresis with dextran sulfate cellulose. Rare cases of anaphylactoid reactions have been reported in patients undergoing sensitization treatment with hymenoptera (bee, wasp) venom while receiving ACE inhibitors.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypotension/syncope: Symptomatic hypotension with or without syncope can occur (usually with the first several doses); effects are most often observed in volume-depleted patients; correct volume depletion prior to initiation; close monitoring of patient is required especially with initial dosing and dosing increases; blood pressure must be lowered at a rate appropriate for the patient's clinical condition. Although dose reduction may be necessary, hypotension is not a reason for discontinuation of future ACE inhibitor use especially in patients with heart failure where a reduction in systolic blood pressure is a desirable observation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Neutropenia/agranulocytosis: Another ACE Inhibitor, captopril, has been associated with rare cases of agranulocytosis, neutropenia, or leukopenia with myeloid hypoplasia. Patients with renal impairment are at high risk of developing neutropenia. Patients with both renal impairment and collagen vascular disease (eg, systemic lupus erythematosus) are at an even higher risk of developing neutropenia. Periodically monitor CBC with differential in these patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Peripheral edema: The most common side effect of verapamil is peripheral edema; occurs within 2-3 weeks of starting therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal function deterioration: May be associated with deterioration of renal function and/or increases in serum creatinine, particularly in patients with low renal blood flow (eg, renal artery stenosis, heart failure) whose glomerular filtration rate (GFR) is dependent on efferent arteriolar vasoconstriction by angiotensin II; deterioration may result in oliguria, acute renal failure, and progressive azotemia. Small increases in serum creatinine may occur following initiation; consider discontinuation only in patients with progressive and/or significant deterioration in renal function.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Aortic stenosis: Use with caution in patients with severe aortic stenosis; may reduce coronary perfusion resulting in ischemia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Initiation of therapy in patients with ischemic heart disease or cerebrovascular disease warrants close observation due to the potential consequences posed by falling blood pressure (eg, MI, stroke). Fluid replacement, if needed, may restore blood pressure; therapy may then be resumed. Discontinue therapy in patients whose hypotension recurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cirrhosis: Dosage adjustments of trandolapril are needed in patients with hepatic cirrhosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Collagen vascular disease: Use trandolapril with caution in patients with collagen vascular disease especially with concomitant renal impairment; may be at increased risk for hematologic toxicity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Heart failure: Avoid verapamil in heart failure; can exacerbate condition. Contraindicated with severe left ventricular dysfunction or cardiogenic shock.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use verapamil with caution in patients with hepatic impairment; may require lower starting dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypertrophic obstructive cardiomyopathy (HOCM): Use with caution in patients with HOCM.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal artery stenosis: Use trandolapril with caution in patients with unstented unilateral/bilateral renal artery stenosis. When unstented bilateral renal artery stenosis is present, use is generally avoided due to the elevated risk of deterioration in renal function unless possible benefits outweigh risks.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in pre-existing renal insufficiency; dosage adjustment is needed in severe renal dysfunction (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute). Avoid rapid dosage escalation which may lead to further renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Angiotensin receptor blockers (ARBs) and renin inhibitors: Concomitant use of an ARB or renin inhibitor (eg, aliskiren) is associated with an increased risk of hypotension, hyperkalemia, and renal dysfunction. Concomitant use with aliskiren should be avoided in patients with GFR &lt;60 mL/minute and is contraindicated in patients with diabetes mellitus (regardless of GFR).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Digoxin: Verapamil significantly increases digoxin serum concentrations; adjust digoxin dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Neuromuscular-blocking agents: Verapamil may prolong recovery from nondepolarizing neuromuscular-blocking agents.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pregnancy:",
"     <b>",
"      [U.S. Boxed Warning]: Drugs that act on the renin-angiotensin system can cause injury and death to the developing fetus. Discontinue as soon as possible once pregnancy is detected.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Surgery: Use with caution before, during, or immediately after major surgery. Cardiopulmonary bypass, intraoperative blood loss or vasodilating anesthesia increases endogenous renin release. Use of ACE inhibitors perioperatively will blunt angiotensin II formation and may result in hypotension.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F229941\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F229917\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): Verapamil may increase the serum concentration of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aliskiren: May enhance the hyperkalemic effect of ACE Inhibitors. Aliskiren may enhance the hypotensive effect of ACE Inhibitors. Aliskiren may enhance the nephrotoxic effect of ACE Inhibitors. Management: Avoid aliskiren use with ACEIs or ARBs in patients with diabetes or estimated glomerular filtration rate below 60 mL/min. In other patients receiving these combinations, monitor serum potassium, serum creatinine, and blood pressure periodically.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aliskiren: Verapamil may increase the serum concentration of Aliskiren.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Allopurinol: ACE Inhibitors may enhance the potential for allergic or hypersensitivity reactions to Allopurinol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha1-Blockers: May enhance the hypotensive effect of Calcium Channel Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amifostine: Antihypertensives may enhance the hypotensive effect of Amifostine.  Management: When amifostine is used at chemotherapy doses, antihypertensive medications should be withheld for 24 hours prior to amifostine administration. If antihypertensive therapy can not be withheld, amifostine should not be administered.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amiodarone: Calcium Channel Blockers (Nondihydropyridine) may enhance the bradycardic effect of Amiodarone. Sinus arrest has been reported.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Angiotensin II Receptor Blockers: May enhance the adverse/toxic effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anilidopiperidine Opioids: May enhance the bradycardic effect of Calcium Channel Blockers (Nondihydropyridine). Anilidopiperidine Opioids may enhance the hypotensive effect of Calcium Channel Blockers (Nondihydropyridine).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antacids: May decrease the serum concentration of ACE Inhibitors. Management: Separate fosinopril administration from antacids by at least 2 hours. US and Canadian recommendations for use of other ACE- inhibitors with antacids may vary. Consult appropriate labeling. Monitor for decreased therapeutic effects of ACE-inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antifungal Agents (Azole Derivatives, Systemic): May enhance the adverse/toxic effect of Calcium Channel Blockers. Specifically, itraconazole may enhance the negative inotropic effects of verapamil or diltiazem. Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Calcium Channel Blockers. Management: Concurrent use of felodipine or nisoldipine with itraconazole is specifically contraindicated.  Frequent monitoring is warranted with any such combination; calcium channel blocker dose reductions may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antihypertensives: May enhance the hypotensive effect of other Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aprotinin: May diminish the antihypertensive effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtorvaSTATin: May increase the serum concentration of Verapamil. Verapamil may increase the serum concentration of AtorvaSTATin. Management: Consider using lower atorvastatin doses when used together with verapamil.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Avanafil: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Avanafil.  Management: The maximum avanafil adult dose is 50 mg per 24-hour period when used together with a moderate CYP3A4 inhibitor.  Patients receiving such a combination should also be monitored more closely for evidence of adverse effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AzaTHIOprine: ACE Inhibitors may enhance the myelosuppressive effect of AzaTHIOprine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May increase the metabolism of Calcium Channel Blockers. Management: Monitor for decreased therapeutic effects of calcium channel blockers with concomitant barbiturate therapy. Calcium channel blocker dose adjustments may be necessary. Nimodipine Canadian labeling contraindicates concomitant use with phenobarbital.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzodiazepines (metabolized by oxidation): Calcium Channel Blockers (Nondihydropyridine) may decrease the metabolism of Benzodiazepines (metabolized by oxidation).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: Calcium Channel Blockers (Nondihydropyridine) may enhance the hypotensive effect of Beta-Blockers. Bradycardia and signs of heart failure have also been reported. Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levobunolol; Metipranolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Bosutinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Bosutinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Budesonide (Systemic, Oral Inhalation): CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Budesonide (Systemic, Oral Inhalation).  Management: Consider reducing the oral budesonide dose when used together with a CYP3A4 inhibitor.  This interaction is likely less severe with orally inhaled budesonide.  Monitor patients closely for signs/symptoms of corticosteroid excess.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BusPIRone: Calcium Channel Blockers (Nondihydropyridine) may decrease the metabolism of BusPIRone.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers (Dihydropyridine): May enhance the hypotensive effect of Calcium Channel Blockers (Nondihydropyridine). Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Calcium Channel Blockers (Dihydropyridine).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Salts: May diminish the therapeutic effect of Calcium Channel Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May decrease the serum concentration of Calcium Channel Blockers (Nondihydropyridine). Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of CarBAMazepine. Management: Consider empiric reductions in carbamazepine dose with initiation of nondihydropyridine calcium channel blockers. Monitor for increased toxic effects of carbamazepine and reduced therapeutic effects of the calcium channel blocker.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: Calcium Channel Blockers (Nondihydropyridine) may enhance the AV-blocking effect of Cardiac Glycosides. Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Cardiac Glycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cimetidine: May increase the serum concentration of Calcium Channel Blockers. Management: Consider alternatives to cimetidine. If no suitable alternative exists, monitor for increased effects of calcium channel blockers following cimetidine initiation/dose increase, and decreased effects following cimetidine discontinuation/dose decrease.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloNIDine: May enhance the AV-blocking effect of Calcium Channel Blockers (Nondihydropyridine). Sinus node dysfunction may also be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Clopidogrel: Calcium Channel Blockers may diminish the therapeutic effect of Clopidogrel.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colchicine: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Colchicine.  Management: Reduce colchicine dose as directed when using with a moderate CYP3A4 inhibitor, and increase monitoring for colchicine-related toxicity.  Use extra caution in patients with impaired renal and/or hepatic function.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colchicine: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Colchicine. Colchicine distribution into certain tissues (e.g., brain) may also be increased.  Management: Colchicine is contraindicated in patients with impaired renal or hepatic function who are also receiving a p-glycoprotein inhibitor.  In those with normal renal and hepatic function, reduce colchicine dose as directed.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): Calcium Channel Blockers (Nondihydropyridine) may decrease the metabolism of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): ACE Inhibitors may enhance the nephrotoxic effect of CycloSPORINE (Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): May decrease the metabolism of Calcium Channel Blockers (Nondihydropyridine). Calcium Channel Blockers (Nondihydropyridine) may decrease the metabolism of CycloSPORINE (Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Substrates: CYP3A4 Inhibitors (Moderate) may decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: Verapamil may increase serum concentrations of the active metabolite(s) of Dabigatran Etexilate.  Management: Consider giving dabigatran 2 hrs before oral verapamil; other dose reductions may be needed. Specific recommendations vary by US vs Canadian labeling, renal function, and indication for dabigatran.  Refer to full monograph or dabigatran labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dantrolene: May enhance the hyperkalemic effect of Calcium Channel Blockers (Nondihydropyridine). Dantrolene may enhance the negative inotropic effect of Calcium Channel Blockers (Nondihydropyridine). Management: This interaction has only been described with intravenous dantrolene administration.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Diazoxide: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disopyramide: Verapamil may enhance the adverse/toxic effect of Disopyramide. Of particular concern is the potential for profound depression of myocardial contractility.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dofetilide: Verapamil may increase the serum concentration of Dofetilide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     DPP-IV Inhibitors: May enhance the adverse/toxic effect of ACE Inhibitors. Specifically, the risk of angioedema may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dronedarone: Calcium Channel Blockers (Nondihydropyridine) may enhance the AV-blocking effect of Dronedarone. Other electrophysiologic effects of Dronedarone may also be increased. Dronedarone may increase the serum concentration of Calcium Channel Blockers (Nondihydropyridine). Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Dronedarone.  Management: Use lower starting doses of the nondihydropyridine calcium channel blockers (i.e., verapamil, diltiazem), and only consider increasing calcium channel blocker dose after obtaining ECG-based evidence that the combination is being well-tolerated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eletriptan: Calcium Channel Blockers (Nondihydropyridine) may decrease the metabolism of Eletriptan.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eplerenone: Calcium Channel Blockers (Nondihydropyridine) may decrease the metabolism of Eplerenone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eplerenone: May enhance the hyperkalemic effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Everolimus: May enhance the adverse/toxic effect of ACE Inhibitors. Specifically, the risk of angioedema may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ferric Gluconate: ACE Inhibitors may enhance the adverse/toxic effect of Ferric Gluconate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fexofenadine: Verapamil may increase the bioavailability of Fexofenadine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fingolimod: Verapamil may enhance the bradycardic effect of Fingolimod.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Flecainide: Verapamil may enhance the adverse/toxic effect of Flecainide. In particular, this combination may significantly impair myocardial contractility and AV nodal conduction.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fluconazole: May decrease the metabolism of Calcium Channel Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: Calcium Channel Blockers may increase the serum concentration of Fosphenytoin.  Management: Monitor for phenytoin toxicity with concomitant use of a calcium channel blocker (CCB) or decreased phenytoin effects with CCB discontinuation. Monitor for decreased CCB therapeutic effects. Nimodipine Canadian labeling contraindicates use with phenytoin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gold Sodium Thiomalate: ACE Inhibitors may enhance the adverse/toxic effect of Gold Sodium Thiomalate. An increased risk of nitritoid reactions has been appreciated.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Grapefruit Juice: May increase the serum concentration of Verapamil.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Halofantrine: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Halofantrine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypertensive Properties): May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypotensive Properties): May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypotensive Agents: May enhance the adverse/toxic effect of other Hypotensive Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Icatibant: May diminish the antihypertensive effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ifosfamide: CYP3A4 Inhibitors (Moderate) may decrease serum concentrations of the active metabolite(s) of Ifosfamide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iron Dextran Complex: ACE Inhibitors may enhance the adverse/toxic effect of Iron Dextran Complex. Specifically, patients receiving an ACE inhibitor may be at an increased risk for anaphylactic-type reactions.  Management: Follow iron dextran recommendations closely regarding both having resuscitation equipment and trained personnel on-hand prior to iron dextran administration and the use of a test dose prior to the first therapeutic dose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivabradine: Calcium Channel Blockers (Nondihydropyridine) may enhance the bradycardic effect of Ivabradine. Ivabradine may enhance the QTc-prolonging effect of Calcium Channel Blockers (Nondihydropyridine). Specifically, the QTc prolonging effects of bepridil may be enhanced. Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Ivabradine. Specifically, verapamil or diltiazem may increase serum ivabradine concentrations.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Ivacaftor.  Management: Decrease ivacaftor dose to 150 mg daily in patients also receiving moderate CYP3A4 inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lanthanum: May decrease the serum concentration of ACE Inhibitors. Management: Administer angiotensin-converting enzyme inhibitors at least two hours before or after lanthanum.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: ACE Inhibitors may increase the serum concentration of Lithium.  Management: Lithium dosage reductions will likely be needed following the addition of an ACE inhibitor.  Monitor patient response to lithium closely following addition or discontinuation of concurrent ACE inhibitor treatment.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: Calcium Channel Blockers (Nondihydropyridine) may enhance the neurotoxic effect of Lithium. Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Lithium. Decreased or unaltered lithium concentrations have also been reported with this combination.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Lomitapide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loop Diuretics: May enhance the hypotensive effect of ACE Inhibitors. Specifically, postural hypotension which can accompany ACE Inhibitor initiation. Loop Diuretics may enhance the nephrotoxic effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lovastatin: Verapamil may increase the serum concentration of Lovastatin.  Management: Initiate lovastatin at a maximum adult dose of 10 mg/day, and do not exceed 20 mg/day, in patients receiving verapamil. Monitor closely for signs of HMG-CoA reductase inhibitor toxicity (e.g., myositis, rhabdomyolysis).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lurasidone: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Lurasidone.  Management: U.S. labeling: start at 20 mg/day and limit to max of 80 mg/day with moderate CYP3A4 inhibitor.  Canadian labeling: limit to max of 40 mg/day with moderate CYP3A4 inhibitor; avoid concomitant use of grapefruit products.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Macrolide Antibiotics: May decrease the metabolism of Calcium Channel Blockers. Management: Consider using a noninteracting macrolide. Monitor for increased therapeutic effects of calcium channel blockers if an interacting macrolide antibiotic is initiated, or decreased effects if a macrolide is discontinued.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Azithromycin (Systemic); Fidaxomicin; Spiramycin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Salts: Calcium Channel Blockers may enhance the adverse/toxic effect of Magnesium Salts. Magnesium Salts may enhance the hypotensive effect of Calcium Channel Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Midodrine: Calcium Channel Blockers (Nondihydropyridine) may enhance the bradycardic effect of Midodrine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nafcillin: May increase the metabolism of Calcium Channel Blockers.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular-Blocking Agents (Nondepolarizing): Calcium Channel Blockers may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents (Nondepolarizing).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nitroprusside: Calcium Channel Blockers may enhance the hypotensive effect of Nitroprusside.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: ACE Inhibitors may enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents. Specifically, the combination may result in a significant decrease in renal function. Nonsteroidal Anti-Inflammatory Agents may diminish the antihypertensive effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inducers: May decrease the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inducers may also further limit the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inhibitors: May increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Substrates: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: Calcium Channel Blockers may increase the serum concentration of Phenytoin.  Management: Monitor for phenytoin toxicity with concomitant use of a calcium channel blocker (CCB) or decreased phenytoin effects with CCB discontinuation. Monitor for decreased CCB therapeutic effects. Nimodipine Canadian labeling contraindicates use with phenytoin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphodiesterase 5 Inhibitors: May enhance the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: CYP3A4 Inhibitors (Moderate) may decrease the metabolism of Pimecrolimus.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pomalidomide: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Pomalidomide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium Salts: May enhance the hyperkalemic effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium-Sparing Diuretics: May enhance the hyperkalemic effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Propafenone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protease Inhibitors: May decrease the metabolism of Calcium Channel Blockers (Nondihydropyridine). Increased serum concentrations of the calcium channel blocker may increase risk of AV nodal blockade. Management: Avoid concurrent use when possible. If this combination is used, monitor for evidence of toxicity. The manufacturer of atazanavir recommends a 50% dose reduction for diltiazem be considered. Saquinavir or tipranavir use with bepridil is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prucalopride: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Prucalopride.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: May enhance the hypotensive effect of Verapamil. Verapamil may increase the serum concentration of QuiNIDine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ranolazine: Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Ranolazine.  Management: Limit ranolazine dose to a maximum of 500 mg twice daily when used with diltiazem or verapamil.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Red Yeast Rice: Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Red Yeast Rice. Specifically, concentrations of lovastatin (and possibly other related compounds) may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May increase the metabolism of Calcium Channel Blockers. This primarily affects oral forms of calcium channel blockers. Management: The labeling for some U.S. and Canadian calcium channel blockers contraindicate use with rifampin however recommendations vary. Consult appropriate labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RisperiDONE: Verapamil may increase the serum concentration of RisperiDONE.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RiTUXimab: Antihypertensives may enhance the hypotensive effect of RiTUXimab.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: Verapamil may increase the serum concentration of Rivaroxaban.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May diminish the antihypertensive effect of ACE Inhibitors. They may also diminish other beneficial pharmacodynamic effects desired for the treatment of CHF.  The effects are likely dose-related.  100 mg doses aspirin appear to cause no problems, whereas 300 mg doses appear to significantly affect ACE Inhibitor efficacy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: Calcium Channel Blockers (Nondihydropyridine) may enhance the anticoagulant effect of Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salmeterol: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Salmeterol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Simvastatin: Verapamil may increase the serum concentration of Simvastatin.  Management: Avoid concurrent use of verapamil with simvastatin when possible.   If used together, limit adult maximum simvastatin dose to 10 mg/day, and avoid Simcor (simvastatin/niacin) because fixed simvastatin doses in the product exceed this maximum.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sirolimus: May enhance the adverse/toxic effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Phosphates: ACE Inhibitors may enhance the nephrotoxic effect of Sodium Phosphates. Specifically, the risk of acute phosphate nephropathy may be enhanced.  Management: Consider avoiding this combination by temporarily suspending treatment with ACEIs, or seeking alternatives to oral sodium phosphate bowel preparation. If the combination cannot be avoided, maintain adequate hydration and monitor renal function closely.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Systemic): Calcium Channel Blockers (Nondihydropyridine) may decrease the metabolism of Tacrolimus (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): Calcium Channel Blockers (Nondihydropyridine) may decrease the metabolism of Tacrolimus (Topical).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telithromycin: May enhance the hypotensive effect of Verapamil.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Temsirolimus: May enhance the adverse/toxic effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: May enhance the hypotensive effect of ACE Inhibitors. Specifically, postural hypotension which can accompany ACE Inhibitor initiation. Thiazide Diuretics may enhance the nephrotoxic effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     TiZANidine: May enhance the hypotensive effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tolvaptan: May enhance the hyperkalemic effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topotecan: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Topotecan.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trimethoprim: May enhance the hyperkalemic effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vilazodone: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Vilazodone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     VinCRIStine (Liposomal): P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of VinCRIStine (Liposomal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Yohimbine: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zuclopenthixol: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Zuclopenthixol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F229918\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     D (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F1624133\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      [U.S. Boxed Warning]: Drugs that act on the renin-angiotensin system can cause injury and death to the developing fetus. Discontinue as soon as possible once pregnancy is detected.",
"     </b>",
"     Also see individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F229937\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/contraindicated",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F229927\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, controlled release",
"     </b>",
"     (Tarka Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1-240 mg (100): $463.93",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2-180 mg (100): $463.93",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2-240 mg (100): $463.93",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4-240 mg (100): $463.93",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F6180284\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood pressure and heart rate; serum creatinine and potassium; if patient has collagen vascular disease and/or renal impairment, periodically monitor CBC with differential",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F229928\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Tarka (AR, AT, AU, CH, CO, CR, CZ, DE, DK, EE, ES, FI, FR, GB, GT, HK, HN, ID, IE, IT, NI, NL, PA, PE, PH, PK, SE, SV, VE, ZA);",
"     </li>",
"     <li>",
"      Tarka LP (FR);",
"     </li>",
"     <li>",
"      Udramil (DE);",
"     </li>",
"     <li>",
"      Ziaxel (NZ)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F229925\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Chobanian AV, Bakris GL, Black HR, et al, &ldquo;The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2003, 289(19):2560-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/29/37336/abstract-text/12748199/pubmed\" id=\"12748199\" target=\"_blank\">",
"        12748199",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kaplan NM and Sever PS, &ldquo;Combination Therapy: A Key to Comprehensive Patient Care,&rdquo;",
"      <i>",
"       Am J Hypertens",
"      </i>",
"      , 1997, 10(7 Pt 2):127S.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/29/37336/abstract-text/9231887/pubmed\" id=\"9231887\" target=\"_blank\">",
"        9231887",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Moser M and Black HR, &ldquo;The Role of Combination Therapy in the Treatment of Hypertension,&rdquo;",
"      <i>",
"       Am J Hypertens",
"      </i>",
"      , 1998, 11(6 Pt 2):73S-8S, 95S-100S.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/29/37336/abstract-text/9655566/pubmed\" id=\"9655566\" target=\"_blank\">",
"        9655566",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10100 Version 43.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-125.39.66.150-9E46D5F071-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_29_37336=[""].join("\n");
var outline_f36_29_37336=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708901\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229930\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229931\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229946\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229932\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229933\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229934\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229935\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229921\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229911\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229923\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229944\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6363258\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529361\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229941\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229917\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229918\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1624133\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229937\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229927\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6180284\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229928\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229925\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10100\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10100|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?16/47/17141?source=related_link\">",
"      Trandolapril and verapamil: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_29_37337="PANDAS: Pediatric autoimmune neuropsychiatric disorder associated with group A streptococci";
var content_f36_29_37337=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   PANDAS: Pediatric autoimmune neuropsychiatric disorder associated with group A streptococci",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/29/37337/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/29/37337/contributors\">",
"     Michael E Pichichero, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/29/37337/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/29/37337/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/29/37337/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/29/37337/contributors\">",
"     Thomas JA Lehman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/29/37337/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/29/37337/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/29/37337/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediatric autoimmune neuropsychiatric disorder associated with group A streptococci (PANDAS) is a term used to describe a subset of children whose symptoms of obsessive compulsive disorder (OCD) or tic disorders are exacerbated by group A streptococcal (GAS) infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1\">",
"     1",
"    </a>",
"    ]. The hypothesized association between PANDAS and GAS is controversial, as is the limitation of the diagnosis exclusively within the pediatric age group. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Areas of controversy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    An overview of PANDAS will be presented below. Other aspects of GAS infection in children, including diagnosis, treatment, prevention, and complications, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/28/41417?source=see_link\">",
"     \"Approach to diagnosis of acute infectious pharyngitis in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/30/27110?source=see_link\">",
"     \"Complications of streptococcal tonsillopharyngitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/38/2666?source=see_link\">",
"     \"Treatment and prevention of streptococcal tonsillopharyngitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BACKGROUND",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most of the knowledge about PANDAS has been obtained by studying patients with a known tic disorder or long-standing OCD in research facilities and referral centers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. Investigators at these centers noted an association between Sydenham chorea and OCD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. Sydenham chorea is a movement disorder characterized by chorea, emotional lability, and hypotonia. It is one of the major clinical manifestations of acute rheumatic fever (ARF). The investigators also identified a subset of children with OCD or tic disorders following GAS infection who did not meet criteria for Sydenham chorea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/4,8,9\">",
"     4,8,9",
"    </a>",
"    ]. This subset is described by the acronym PANDAS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/31/22007?source=see_link\">",
"     \"Sydenham chorea\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/20/23879?source=see_link\">",
"     \"Clinical manifestations and diagnosis of acute rheumatic fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnostic criteria for PANDAS, which are discussed in greater detail below, include the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1,10\">",
"     1,10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Obsessive-compulsive disorder (OCD)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      tic disorder (Tourette disorder, chronic motor or vocal tic disorder)",
"     </li>",
"     <li>",
"      Pediatric onset (between three years and onset of puberty)",
"     </li>",
"     <li>",
"      Abrupt onset and episodic course of symptoms",
"     </li>",
"     <li>",
"      Temporal relation between group A streptococcal (GAS) infection and onset",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      exacerbation",
"     </li>",
"     <li>",
"      Neurologic abnormalities, such as motoric hyperactivity, choreiform movements, or tics during exacerbations",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Whether PANDAS is a distinct form of more typical cases of OCD or tic disorder remains controversial; the proposed pathogenesis is also controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. These issues are important because they affect evaluation and management. They are discussed in greater detail below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Areas of agreement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although PANDAS is a controversial diagnosis, there is general agreement on the following points:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      GAS is one of several factors that can exacerbate OCD or tic disorder in a subset of patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1,9,14-17\">",
"       1,9,14-17",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Children with signs and symptoms compatible with GAS infections should be evaluated for GAS infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/10,12\">",
"       10,12",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/28/41417?source=see_link&amp;anchor=H16#H16\">",
"       \"Approach to diagnosis of acute infectious pharyngitis in children and adolescents\", section on 'Diagnostic approach'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Children with GAS infection and",
"      <span class=\"nowrap\">",
"       OCD/tic",
"      </span>",
"      disorder require standard treatments for these problems (regardless of whether GAS and",
"      <span class=\"nowrap\">",
"       OCD/tic",
"      </span>",
"      disorder are causally associated) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/10,12\">",
"       10,12",
"      </a>",
"      ] (see",
"      <a class=\"local\" href=\"#H17\">",
"       'Management'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Routine administration of immunomodulatory therapy (eg, glucocorticoids, plasma exchange, intravenous immunoglobulin [IVIG]) is not indicated for children who meet PANDAS criteria [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/10,12,18\">",
"       10,12,18",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Routine administration of prophylactic antibiotics is not indicated for children who meet PANDAS criteria [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/10,12\">",
"       10,12",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Areas of controversy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Controversies surrounding PANDAS include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Whether PANDAS is sufficiently different from",
"      <span class=\"nowrap\">",
"       OCD/tic",
"      </span>",
"      disorder to be considered a separate entity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/14,17,19\">",
"       14,17,19",
"      </a>",
"      ] (see",
"      <a class=\"local\" href=\"#H9\">",
"       'Clinical features'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      The nature of the association between GAS and PANDAS (eg, causal versus incidental) and whether it is important to single out GAS among the many other precipitants of",
"      <span class=\"nowrap\">",
"       OCD/tic",
"      </span>",
"      disorders [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/13,14,17,20-23\">",
"       13,14,17,20-23",
"      </a>",
"      ] (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Association with GAS'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Whether PANDAS is an autoimmune disorder [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/19,20\">",
"       19,20",
"      </a>",
"      ] (see",
"      <a class=\"local\" href=\"#H5\">",
"       'Pathogenesis'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Whether evidence of GAS infection should be sought in children with",
"      <span class=\"nowrap\">",
"       OCD/tic",
"      </span>",
"      disorders [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/11,12,24\">",
"       11,12,24",
"      </a>",
"      ] (see",
"      <a class=\"local\" href=\"#H12\">",
"       'Diagnostic process'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The proposed model for pathogenesis of PANDAS suggests that group A streptococcal (GAS) infection in a susceptible host causes an abnormal immune response with resultant central nervous system manifestations. If this hypothesis is correct, there might be a role for prophylactic antibiotics",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    immune modulating therapies in the prevention and treatment of PANDAS. However, the hypothesis is as yet unproven.",
"   </p>",
"   <p>",
"    The model for PANDAS pathogenesis is based upon the clinical similarities between Sydenham chorea and PANDAS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1\">",
"     1",
"    </a>",
"    ]. The pathogenesis of Sydenham chorea and acute rheumatic fever (ARF) are incompletely understood. However, preceding GAS pharyngitis and an abnormal immune response (in which antibodies directed against GAS antigens cross-react with host antigens in brain and other tissues) are widely accepted as important components. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/8/8327?source=see_link&amp;anchor=H7#H7\">",
"     \"Epidemiology and pathogenesis of acute rheumatic fever\", section on 'Molecular mimicry'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Association with GAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The association between neuropsychiatric symptoms and GAS infection was evaluated in a case-control study from a large health maintenance organization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/9\">",
"     9",
"    </a>",
"    ]. The investigators identified 144 patients with obsessive-compulsive disorder (OCD), Tourette syndrome, or a tic disorder (in a population of about 75,000 children) and matched them with one to five control subjects. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cases were more likely than controls to have had a GAS infection in the three months before onset of neurologic disease (odds ratio [OR] 2.22, 95% CI 1.05-4.69)",
"     </li>",
"     <li>",
"      Cases were more likely than controls to have had multiple GAS infections during the 12 months before onset of neurologic disease (OR 3.1, 95% CI 1.77-8.96)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Prospective studies have confirmed that GAS is associated with the onset or exacerbation of OCD or tic disorder in at least some patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. However, the high background rates of GAS infection, GAS carriage, and",
"    <span class=\"nowrap\">",
"     OCD/tic",
"    </span>",
"    disorders in prepubertal children make it difficult to establish causality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/10,12,13\">",
"     10,12,13",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Autoimmunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of autoimmunity in PANDAS is controversial.",
"   </p>",
"   <p>",
"    Support for a role of autoimmunity is provided by reports of response to treatment with immune-modifying therapies, such as glucocorticoids, intravenous immunoglobulin (IVIG), and plasma exchange [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/4,25,26\">",
"     4,25,26",
"    </a>",
"    ]. The response to plasma exchange appears to be specific to children with",
"    <span class=\"nowrap\">",
"     OCD/tic",
"    </span>",
"    disorders and preceding GAS infection; in an open trial, plasma provided no benefit for children with OCD whose symptom exacerbation did not follow GAS infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An autoimmune mechanism for PANDAS also is supported by animal studies, as well as studies demonstrating increased antineuronal antibodies in patients with PANDAS compared with patients with",
"    <span class=\"nowrap\">",
"     OCD/tic",
"    </span>",
"    disorders but no evidence of GAS infection and patients with GAS infection but without",
"    <span class=\"nowrap\">",
"     OCD/tic",
"    </span>",
"    disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/26,28-30\">",
"     26,28-30",
"    </a>",
"    ]. However, other studies have been unable to distinguish patients with PANDAS or Tourette syndrome from control patients on the basis of autoantibody profiles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/31-34\">",
"     31-34",
"    </a>",
"    ]. The inconsistent findings may be related to methodologic differences [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional observations that conflict with the hypothesis that PANDAS is caused by antineuronal antibodies include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The failure of immunologic markers to correlate with clinical exacerbations in PANDAS patients in a longitudinal case-control study [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/37\">",
"       37",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The failure of microinfusion of PANDAS serum into rodent striatum to produce changes in behavior [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/38\">",
"       38",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence and prevalence of PANDAS are not known, although it is rare. In our prospective study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/22\">",
"     22",
"    </a>",
"    ], only 10 cases were identified among 30,000 throat cultures positive for GAS; since then, the annual incidence has ranged between 0 per 10,000 cultures to 10 per 30,000 cultures, depending upon the strain of GAS and host genetics (unpublished data) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/39\">",
"     39",
"    </a>",
"    ]. Despite its rarity, some investigators suggest that it may account for &ge;10 percent of childhood-onset OCD and tic disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/40,41\">",
"     40,41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the original series of 50 patients, the mean age of onset was 6.3 years for children with tics and 7.4 years for children with OCD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1\">",
"     1",
"    </a>",
"    ]. PANDAS was more common among boys and children with a family history of rheumatic fever.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H593033002\">",
"    <span class=\"h2\">",
"     Working diagnostic criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;PANDAS is characterized by five working criteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1,4,10\">",
"     1,4,10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Obsessive-compulsive disorder (OCD)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      tic disorder (Tourette, chronic motor, or vocal tic disorder that meets the DSM-IV diagnostic criteria). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/40/18058?source=see_link&amp;anchor=H3#H3\">",
"       \"Hyperkinetic movement disorders in children\", section on 'Tic disorders'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pediatric onset (between three years and onset of puberty).",
"     </li>",
"     <li>",
"      Abrupt onset and episodic course of symptoms. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Clinical course'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Temporal relation between group A streptococcal (GAS) infection and onset",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      exacerbation. The time frame for the temporal relation was not specified in the original description [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1\">",
"       1",
"      </a>",
"      ]. Antibody levels to streptolysin O and DNase B remain elevated for several months after an acute infection, complicating the applicability and interpretation of elevated titers [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/42\">",
"       42",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Laboratory features'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Neurologic abnormalities, such as motoric hyperactivity, choreiform movements (elicited through stressed postures, but not present at rest), or tics during exacerbations. Frank chorea (rapid, irregular, and nonstereotypic jerks that are continuous while the patient is awake but improve with sleep) suggests Sydenham chorea. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/31/22007?source=see_link\">",
"       \"Sydenham chorea\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some experts have questioned whether the above criteria are useful in distinguishing patients with PANDAS from patients with more typical cases of OCD or tic disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/11,12,19\">",
"     11,12,19",
"    </a>",
"    ]. However, observational studies suggest that clinical and laboratory features can distinguish PANDAS from OCD or tic disorder without PANDAS:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a prospective study, 12 children with PANDAS were identified in a primary care practice over a three-year period [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/15\">",
"       15",
"      </a>",
"      ]. All had positive throat cultures at the time of onset of neuropsychiatric symptoms and improvement of neuropsychiatric symptoms with antibiotic therapy. Symptoms resolved completely in four patients within 5 to 21 days after onset, and none of these patients had a recurrence. Recurrent symptoms developed in the remaining children, and each recurrence was associated with a new episode of culture-proven GAS tonsillopharyngitis and amelioration of symptoms with antibiotic therapy.",
"     </li>",
"     <li>",
"      In another study of 109 prepubertal children with tics, OCD, or both, dramatic onset of symptoms, remissions in neuropsychiatric symptoms, a clinical course marked by definite remissions, and remission of neuropsychiatric symptoms during antibiotic therapy were more likely among the 48 children with who met criteria for PANDAS (including positive GAS culture or rising antibody titers at the onset or exacerbation of neuropsychiatric symptoms) than those who did not [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Clinical course",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical course of PANDAS is characterized by a \"sawtooth\" pattern with periods of symptom quiescence, followed by exacerbations with abrupt onset and gradual resolution (over weeks to months) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1,4,10,15\">",
"     1,4,10,15",
"    </a>",
"    ]. Abrupt onset of",
"    <span class=\"nowrap\">",
"     OCD/tic",
"    </span>",
"    disorder symptoms also has been noted in patients without PANDAS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/13,44\">",
"     13,44",
"    </a>",
"    ]. Neuropsychiatric exacerbations in children with PANDAS begin at the time of GAS infection or within one to two weeks after GAS infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1,10,15\">",
"     1,10,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children with PANDAS and tics occasionally have simultaneous onset of frequent, severe, and varied motor and vocal tics, prompting emergency treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/10\">",
"     10",
"    </a>",
"    ]. This is in contrast to the typical onset of isolated, intermittent, simple motor or vocal tic that has a much more gradual onset and is milder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/10,45\">",
"     10,45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similarly, children with PANDAS and OCD are described as having an \"explosion\" of OCD symptoms, reaching clinically significant impairment in 24 to 48 hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1\">",
"     1",
"    </a>",
"    ]. This is in contrast to the typical undulating waxing and waning pattern of OCD symptoms in patients without PANDAS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/46,47\">",
"     46,47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because fever and other stressors of illness are known to exacerbate OCD and tic disorders, to meet criteria for PANDAS, the exacerbations should have an association with GAS infection, documented by culture or serology to qualify as a possible case [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Laboratory features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnosis of PANDAS requires a temporal relation between GAS infection and the onset",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    exacerbation of neuropsychiatric abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1,10\">",
"     1,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    GAS infection is confirmed by:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Positive throat or skin culture or rapid antigen detection test for GAS at the beginning of a PANDAS exacerbation, or",
"     </li>",
"     <li>",
"      Clinically significant rise in antistreptococcal antibody between the onset of symptoms and four to six weeks later. It is important to obtain anti-DNase B as well as anti-streptolysin O titers since anti-DNase B titers are elevated in approximately 80 percent of PANDAS cases, whereas ASO titers are significantly elevated in 20 to 50 percent of cases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some authorities suggest repeat cultures",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    serology when children with suspected recurrent episodes of PANDAS are well to exclude streptococcal carriers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1,10,48\">",
"     1,10,48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC PROCESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;PANDAS is a clinical diagnosis. It may be suspected in children with an abrupt onset of neuropsychiatric symptoms, recent group A streptococcal (GAS) infection, and remission of neuropsychiatric symptoms with antibiotic therapy. The obsessive-compulsive disorder",
"    <span class=\"nowrap\">",
"     (OCD)/tic",
"    </span>",
"    disorder and acute GAS infection should be treated as outlined below. Patients with suspected PANDAS should be monitored for recurrence of neuropsychiatric symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    GAS infection because approximately 50 percent have second episodes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Management'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    We suggest that children who present with abrupt onset of",
"    <span class=\"nowrap\">",
"     OCD/tic",
"    </span>",
"    disorder be evaluated for GAS infection.",
"   </p>",
"   <p>",
"    Diagnosis of PANDAS requires prospective evaluation with documentation of an episode of neuropsychiatric symptoms associated with evidence of GAS infection. Evidence of GAS is provided by [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1,10,48\">",
"     1,10,48",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A positive throat or skin culture or rapid antigen detection test for GAS, or",
"     </li>",
"     <li>",
"      A rise in antistreptococcal antibody (ASO",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      anti-DNase B) titers (twofold or greater)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Demonstration of negative throat culture or declining antistreptococcal antibody titers during remission of neuropsychiatric symptoms is helpful in distinguishing GAS carriers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnostic process described above is that which is outlined by investigators at the National Institutes of Mental Health (NIMH) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1,10\">",
"     1,10",
"    </a>",
"    ]. They maintain that the risk of acute rheumatic fever mandates the detection and appropriate treatment of GAS infections, including mildly symptomatic infections and infections in which neuropsychiatric manifestations are the only symptoms. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/2/44070?source=see_link\">",
"     \"Treatment and prevention of acute rheumatic fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, this process is not endorsed by all experts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Until a causal relationship between PANDAS and GAS infection is established, the American Heart Association (AHA) Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee does not recommend routine laboratory testing for GAS to diagnose PANDAS in children with",
"    <span class=\"nowrap\">",
"     OCD/tic",
"    </span>",
"    disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The evaluation of children with pharyngitis in the absence of neuropsychiatric manifestations is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/31/39415?source=see_link\">",
"     \"Evaluation of sore throat in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/28/41417?source=see_link&amp;anchor=H16#H16\">",
"     \"Approach to diagnosis of acute infectious pharyngitis in children and adolescents\", section on 'Diagnostic approach'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major considerations in the differential diagnosis of PANDAS are obsessive-compulsive disorder",
"    <span class=\"nowrap\">",
"     (OCD)/tic",
"    </span>",
"    disorder in a child with coincident or intercurrent episodes of group A streptococcal (GAS) or a child with GAS carriage and Sydenham chorea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1,10,12,49\">",
"     1,10,12,49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Tic disorder or OCD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both neuropsychiatric symptoms and GAS are common in prepubertal children. OCD occurs in 1 to 2 percent of school-age children and transient motor tics in as many as 25 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/50-52\">",
"     50-52",
"    </a>",
"    ]. GAS accounts for 15 to 30 percent of all cases of pharyngitis in children between the ages of 5 and 15 years. Prospective surveillance identified GAS carriage in 2.5 percent of well children and 4.4 percent of children with URI (including a sore throat) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/28/41417?source=see_link&amp;anchor=H4#H4\">",
"     \"Approach to diagnosis of acute infectious pharyngitis in children and adolescents\", section on 'Group A streptococcus'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/38/6758?source=see_link&amp;anchor=H12#H12\">",
"     \"Antibiotic failure in the treatment of streptococcal tonsillopharyngitis\", section on 'Streptococcal carriage'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Strict adherence to the diagnostic process described above should help to distinguish between PANDAS and coincidental simultaneous occurrence of these problems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/10\">",
"     10",
"    </a>",
"    ]. Documenting negative throat culture",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    stable antistreptococcal antibody titers during remission helps to exclude GAS carriage. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Diagnostic process'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Sydenham chorea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sydenham chorea is a movement disorder characterized by chorea, emotional lability, and hypotonia. Neuropsychiatric manifestations that may be present in Sydenham chorea also may occur in PANDAS patients (eg, OCD, separation anxiety, hyperactivity, adventitious movements) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/6,49,54\">",
"     6,49,54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/31/22007?source=see_link\">",
"     \"Sydenham chorea\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The natural history of PANDAS was described in a prospective case-control study of 40 children with PANDAS and 40 children with obsessive-compulsive disorder",
"    <span class=\"nowrap\">",
"     (OCD)/tic",
"    </span>",
"    disorders but no evidence of group A streptococcal (GAS) infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/14\">",
"     14",
"    </a>",
"    ]. Throat cultures were obtained once per month, and streptococcal antibody titers were measured at least once every three months, for two years; testing for GAS also was performed during exacerbations. Case subjects were treated with standard therapies for their neuropsychiatric symptoms and received prompt antibiotic therapy for GAS infections. Prophylactic antibiotics and immune modulating therapy were not administered. Laboratory personnel were blinded to the status of the patient (case versus control and exacerbation versus routine monitoring), and clinical raters were blinded to the laboratory results.",
"   </p>",
"   <p>",
"    The following observations were made:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Forty neuropsychiatric exacerbations (clinically significant worsening for &ge;5 days unrelated to a change in medication) occurred in 21 case patients (0.56 exacerbations per person year), and 25 neuropsychiatric exacerbations occurred in 14 control subjects (0.28 exacerbations per person year). These rates were lower than expected.",
"     </li>",
"     <li>",
"      Only five neuropsychiatric exacerbations occurred within four weeks of GAS infection; all of these occurred in PANDAS patients. This was greater than the number expected by chance (1.6). However, in a subsequent similarly designed study by the same group, no neuropsychiatric exacerbations occurred within two months of newly diagnosed GAS infection in 31 PANDAS patients who were followed for 25 months [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The majority of exacerbations in PANDAS patients (87.5 percent) had no relation to GAS infection.",
"     </li>",
"     <li>",
"      Definite or probable GAS infection was more frequent among cases than controls (0.43 versus 0.13 infections per person-year, relative risk 2.76, 95% CI 1.4-5.3).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These observations and those from other studies suggest that a subgroup of patients with",
"    <span class=\"nowrap\">",
"     tics/OCD",
"    </span>",
"    may be vulnerable to GAS as a precipitant of neuropsychiatric symptoms, but the majority of exacerbations have other triggers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/14,17,22\">",
"     14,17,22",
"    </a>",
"    ]. In addition, PANDAS has a relatively benign clinical course when neuropsychiatric exacerbations and GAS infection are treated with standard therapies. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Management'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of children with PANDAS centers on providing standard therapies for group A streptococcal (GAS) infection and obsessive-compulsive disorder",
"    <span class=\"nowrap\">",
"     (OCD)/tic",
"    </span>",
"    disorder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/10,12\">",
"     10,12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Antibiotic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotic therapy is indicated for the treatment of acute streptococcal infection as diagnosed by a positive throat or skin culture or rapid antigen detection test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     GAS infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend that children with positive culture or rapid antigen detection test for GAS be treated with antistreptococcal therapy (whether or not they have neuropsychiatric symptoms). Antimicrobial therapy is administered to reduce the severity and duration of signs and symptoms, including suppurative complications, reduce the incidence of nonsuppurative complications (eg, acute rheumatic fever), and reduce the risk of transmission. Treatment of GAS pharyngitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/38/2666?source=see_link\">",
"     \"Treatment and prevention of streptococcal tonsillopharyngitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     PANDAS subgroup",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no randomized controlled trials of antibiotic treatment of children suspected of having PANDAS syndrome. In a prospective study that identified 12 children with abrupt onset of neuropsychiatric symptoms and evidence of recent GAS infection, antistreptococcal (penicillin or cephalosporin) therapy was associated with prompt symptom resolution in all cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/15\">",
"     15",
"    </a>",
"    ]. Antistreptococcal therapy also was associated with prompt resolution of symptoms in the six patients who developed recurrent symptoms associated with GAS infection. The mean time to resolution of symptoms was shorter among children treated with cephalosporin than with penicillin (14 versus 5 to 6 days).",
"   </p>",
"   <p>",
"    Whether prompt antimicrobial treatment of GAS infection prevents the development of neuropsychiatric symptoms is not known [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We suggest that children with suspected PANDAS (ie, abrupt onset of neuropsychiatric symptoms and evidence of recent GAS infection) be treated with antimicrobial therapy, even if the episode of GAS was already treated (given the failure rates for penicillin and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/49/34583?source=see_link\">",
"     amoxicillin",
"    </a>",
"    therapy). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/38/2666?source=see_link&amp;anchor=H13#H13\">",
"     \"Treatment and prevention of streptococcal tonsillopharyngitis\", section on 'Selection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The author of this topic review suggests therapy with a cephalosporin rather than a penicillin. Several alternative regimens are listed below:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/32/32259?source=see_link\">",
"       Cefadroxil",
"      </a>",
"      (30",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day in one dose for 10 days)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?30/5/30804?source=see_link\">",
"       Cephalexin",
"      </a>",
"      (30",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day in two divided doses for 10 days)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?30/61/31701?source=see_link\">",
"       Cefuroxime",
"      </a>",
"      (30",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day in two divided doses for 10 days)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/18/25892?source=see_link\">",
"       Cefpodoxime",
"      </a>",
"      (10",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day in two divided doses for five days)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?6/2/6181?source=see_link\">",
"       Cefdinir",
"      </a>",
"      (14",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day in two divided doses for five days)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Neuropsychiatric therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with OCD",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tic disorders should receive standard neuropsychiatric treatment for these disorders (whether or not the children have evidence of recent GAS infection) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/10,12\">",
"     10,12",
"    </a>",
"    ]. Treatment of neuropsychiatric symptoms should not be delayed pending confirmation of PANDAS (eg, documenting rise in antistreptococcal antibodies or while monitoring for a second episode).",
"   </p>",
"   <p>",
"    The neuropsychiatric manifestations of children in the PANDAS subgroup respond to treatment with standard pharmacologic and behavior therapies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/10\">",
"     10",
"    </a>",
"    ]. OCD symptoms generally respond to a combination of pharmacotherapy (typically a selective serotonin reuptake inhibitor) and cognitive behavior therapy. Motor and vocal tics can be treated with a variety of medications. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/8/22664?source=see_link&amp;anchor=H10#H10\">",
"     \"Tourette syndrome\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Immune modulating therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immune modulating therapies include glucocorticoids, plasma exchange, and intravenous immunoglobulin (IVIG). If PANDAS is an autoimmune disorder (and this remains controversial), immunomodulatory treatments might be beneficial.",
"   </p>",
"   <p>",
"    We recommend not treating children who meet criteria for PANDAS with immune modulating therapies outside of the research setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/10\">",
"     10",
"    </a>",
"    ]. Immune modulating therapy may be an alternative for severely ill patients who have not responded to standard therapies. In such cases, consultation with a specialist in the treatment of neuropsychiatric",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    autoimmune disorders is recommended.",
"   </p>",
"   <p>",
"    The potential benefits of treatment with plasma exchange or IVIG compared with placebo were evaluated in a randomized controlled trial in 29 children who met PANDAS criteria and were severely affected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/25\">",
"     25",
"    </a>",
"    ]. Symptom severity was rated at baseline, and at 1 and 12 months after treatment. Significant improvement in symptoms from baseline was noted in the treatment groups at one month; improvements were maintained at one year, although psychotropic medications were decreased or discontinued in only 7 of 13 patients who required them at baseline. Adverse effects, which occurred in approximately two-thirds of patients in the treatment groups, included nausea, vomiting, headache, and dizziness.",
"   </p>",
"   <p>",
"    Limitations of the trial included the lack of a control for plasma exchange, open treatment of controls after the one-month follow-up (making it impossible to exclude the possibility of spontaneous improvement in the control group at the 12-month follow-up), lack of correlation between therapeutic response and rate of antibody removal, and poorly understood mechanism of therapeutic benefit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/19,25\">",
"     19,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A subsequent open trial of plasma exchange in children with OCD who did not meet PANDAS criteria failed to demonstrate a benefit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/27\">",
"     27",
"    </a>",
"    ]. This finding suggests that the effects of plasma exchange in children with OCD may be limited to those with preceding GAS infection, lending support to the autoimmune hypothesis. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Autoimmunity'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Referral indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Referral to a specialist (neurologist, psychiatrist, mental health provider) for treatment of",
"    <span class=\"nowrap\">",
"     OCD/tic",
"    </span>",
"    disorder may be indicated for children who meet criteria for PANDAS. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Neuropsychiatric therapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Referral to a",
"    <span class=\"nowrap\">",
"     rheumatologist/immunologist",
"    </span>",
"    also may be warranted for patients with severe symptoms that are unresponsive to standard therapies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long-term outcome of children who meet criteria for PANDAS is not known. Cases of carditis (as occurs in patients with Sydenham chorea) have not been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/12\">",
"     12",
"    </a>",
"    ]. Unrecognized PANDAS and untreated PANDAS may result in an increased risk of progression to lifelong obsessive-compulsive disorder (OCD) and tic disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the proposed pathogenetic model for PANDAS described above is correct, it might be possible to prevent PANDAS by preventing group A streptococcal (GAS) infection. Whether the prompt treatment of GAS infection prevents the development of neuropsychiatric symptoms is not known [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. Recognition of the sentinel PANDAS episode and its prompt treatment may impact the likelihood of a recurrence and prevent kindling (eg, repeated stimulation of autoantibodies that target brain tissue, which eventually results in permanent destruction of the brain cells and permanent disability in the form of obsessive-compulsive [OCD] or tic disorder). (See",
"    <a class=\"local\" href=\"#H20\">",
"     'PANDAS subgroup'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     GAS infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measures to prevent GAS infection include early recognition and prompt initiation of antistreptococcal therapy and taking steps to decrease transmission. School-age children with sore throat or unexplained fever should be evaluated for GAS infection and treated with antibiotics if throat culture or rapid antigen detection test is positive. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/28/41417?source=see_link\">",
"     \"Approach to diagnosis of acute infectious pharyngitis in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/38/2666?source=see_link\">",
"     \"Treatment and prevention of streptococcal tonsillopharyngitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    To prevent transmission of GAS infection, children with GAS pharyngitis or skin infection should stay home from school or child care until they have received 24 hours of appropriate antimicrobial therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/23\">",
"     23",
"    </a>",
"    ]. They should avoid close contact with other children during this time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Prophylactic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prophylactic antibiotics prevent recurrences of acute rheumatic fever and Sydenham chorea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/2/44070?source=see_link\">",
"     \"Treatment and prevention of acute rheumatic fever\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/31/22007?source=see_link\">",
"     \"Sydenham chorea\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If, as hypothesized, the pathogenesis of PANDAS is similar to that of acute rheumatic fever and Sydenham chorea, then prophylactic antibiotics might be expected to prevent recurrences of PANDAS as well. However, the pathogenesis of PANDAS has not been established, and the role of prophylactic antibiotics is unknown. Potential adverse effects of prophylactic antibiotic therapy include diarrhea, pseudomembranous colitis, candida infections, and increased rates of antibiotic resistance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the author&rsquo;s experience, prophylactic antibiotics are an option to aid in the diagnosis of PANDAS and prevent symptom recurrences. The clinical course during prophylaxis may help provide insight into the disease for the",
"    <span class=\"nowrap\">",
"     patient/family",
"    </span>",
"    and clinician: remission of neuropsychiatric symptoms helps to establish the diagnosis of PANDAS, whereas recurrence of neuropsychiatric symptoms during prophylaxis excludes the diagnosis. However, other experts recommend against the use of prophylactic antibiotics for children with PANDAS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prophylactic regimen is the same as that for acute rheumatic fever (",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/49/34583?source=see_link\">",
"     amoxicillin",
"    </a>",
"    250 twice per day orally, or [for penicillin allergic children] a macrolide [eg,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/15/35056?source=see_link\">",
"     azithromycin",
"    </a>",
"    5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    orally once per day, maximum dose 250 mg]). Antibiotic prophylaxis is generally continued for one winter season, coinciding with the peak seasonal occurrence of GAS (about six months). Prophylaxis is discontinued if neuropsychiatric symptoms do not improve or the child has a recurrence of neuropsychiatric symptoms.",
"   </p>",
"   <p>",
"    In the only placebo-controlled trial, an equal number of GAS infections occurred in the penicillin and placebo groups; failure to achieve adequate prophylaxis against GAS prohibited drawing conclusions regarding efficacy of PANDAS prevention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/57\">",
"     57",
"    </a>",
"    ]. A subsequent study compared rates of streptococcal infections and neuropsychiatric symptom exacerbation before and during 12 months of prophylaxis with penicillin or",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/15/35056?source=see_link\">",
"     azithromycin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/3\">",
"     3",
"    </a>",
"    ]. Prophylaxis was associated with fewer episodes of GAS infection and fewer neuropsychiatric exacerbations compared with baseline. However, the lack of a placebo group, and other design problems (eg, small numbers, inadequate blinding, nonstandardized definition of exacerbation, failure to exclude GAS carriage), make these results difficult to inconclusive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/29/37337/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      PANDAS (pediatric autoimmune neuropsychiatric disorder associated with group A streptococci) is a term used to describe a subset of children whose symptoms of obsessive-compulsive disorder (OCD) or tic disorders are exacerbated by group A streptococcal (GAS) infection. The hypothesized association between PANDAS and GAS is controversial. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Background'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PANDAS is characterized by five working criteria (see",
"      <a class=\"local\" href=\"#H9\">",
"       'Clinical features'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      OCD",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      tic disorder",
"     </li>",
"     <li>",
"      Pediatric onset (between three years and onset of puberty)",
"     </li>",
"     <li>",
"      Abrupt onset and episodic course of symptoms",
"     </li>",
"     <li>",
"      Temporal relation between GAS infection and onset",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      exacerbation",
"     </li>",
"     <li>",
"      Neurologic abnormalities or tics during exacerbations",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest that children who present with abrupt onset of",
"      <span class=\"nowrap\">",
"       OCD/tic",
"      </span>",
"      disorder be evaluated for GAS infection (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Diagnostic process'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnosis of PANDAS requires prospective evaluation with documentation of an episode of neuropsychiatric symptoms associated with evidence of GAS infection (positive throat or skin culture, rapid antigen detection test, or rising antistreptococcal antibody titers). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Diagnostic process'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that children with positive culture or rapid antigen detection test for GAS be treated with antistreptococcal therapy (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19\">",
"       'GAS infection'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/38/2666?source=see_link\">",
"       \"Treatment and prevention of streptococcal tonsillopharyngitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest that children with abrupt onset OCD",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      tic disorders and evidence of GAS infection (ie, those with possible PANDAS) be treated with antistreptococcal therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). They should receive standard neuropsychiatric treatment for",
"      <span class=\"nowrap\">",
"       OCD/tic",
"      </span>",
"      disorder if the symptoms do not remit after antibiotic therapy. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'PANDAS subgroup'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21\">",
"       'Neuropsychiatric therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend not treating children who meet criteria for PANDAS with immune-modulating therapies outside of the research setting (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Immune modulating therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prophylactic antibiotics are an option to aid in the diagnosis of PANDAS and prevent symptom recurrences. &nbsp;The clinical course during prophylaxis may provide insight into the disease for the",
"      <span class=\"nowrap\">",
"       patient/family",
"      </span>",
"      and clinician: remission of neuropsychiatric symptoms helps to establish the diagnosis of PANDAS, whereas recurrence of neuropsychiatric symptoms during prophylaxis excludes the diagnosis. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Prophylactic therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/1\">",
"      Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998; 155:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/2\">",
"      Swedo SE. Sydenham's chorea. A model for childhood autoimmune neuropsychiatric disorders. JAMA 1994; 272:1788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/3\">",
"      Snider LA, Lougee L, Slattery M, et al. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry 2005; 57:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/4\">",
"      Allen AJ, Leonard HL, Swedo SE. Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 1995; 34:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/5\">",
"      Swedo SE, Rapoport JL, Cheslow DL, et al. High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am J Psychiatry 1989; 146:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/6\">",
"      Swedo SE, Leonard HL, Schapiro MB, et al. Sydenham's chorea: physical and psychological symptoms of St Vitus dance. Pediatrics 1993; 91:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/7\">",
"      Asbahr FR, Negr&atilde;o AB, Gentil V, et al. Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study. Am J Psychiatry 1998; 155:1122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/8\">",
"      Swedo SE, Leonard HL, Kiessling LS. Speculations on antineuronal antibody-mediated neuropsychiatric disorders of childhood. Pediatrics 1994; 93:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/9\">",
"      Mell LK, Davis RL, Owens D. Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder. Pediatrics 2005; 116:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/10\">",
"      Swedo SE, Leonard HL, Rapoport JL. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction. Pediatrics 2004; 113:907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/11\">",
"      Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2009; 119:1541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/12\">",
"      Kurlan R, Kaplan EL. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician. Pediatrics 2004; 113:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/13\">",
"      Shulman ST. Pediatric autoimmune neuropsychiatric disorders associated with streptococci (PANDAS): update. Curr Opin Pediatr 2009; 21:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/14\">",
"      Kurlan R, Johnson D, Kaplan EL, Tourette Syndrome Study Group. Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study. Pediatrics 2008; 121:1188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/15\">",
"      Murphy ML, Pichichero ME. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med 2002; 156:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/16\">",
"      Leslie DL, Kozma L, Martin A, et al. Neuropsychiatric disorders associated with streptococcal infection: a case-control study among privately insured children. J Am Acad Child Adolesc Psychiatry 2008; 47:1166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/17\">",
"      Leckman JF, King RA, Gilbert DL, et al. Streptococcal upper respiratory tract infections and exacerbations of tic and obsessive-compulsive symptoms: a prospective longitudinal study. J Am Acad Child Adolesc Psychiatry 2011; 50:108.",
"     </a>",
"    </li>",
"    <li>",
"     PANDAS Information. Pediatrics and Developmental Neuroscience Branch National Institutes of Mental Health. intramural.nimh.nih.gov/pdn/web.htm (Accessed on September 07, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/19\">",
"      Singer HS. PANDAS and immunomodulatory therapy. Lancet 1999; 354:1137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/20\">",
"      Kaplan EL. PANDAS? PAND? Or both? Or neither? Assessing a (possible?) temporal or pathogenetic relationship with the Group A \"streptococcal diseases complex\". Contemp Pediatr 2000; 18:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/21\">",
"      Luo F, Leckman JF, Katsovich L, et al. Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics 2004; 113:e578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/22\">",
"      Perrin EM, Murphy ML, Casey JR, et al. Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children? Arch Pediatr Adolesc Med 2004; 158:848.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Group A streptococcal infections. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.668.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/24\">",
"      Gilbert DL, Kurlan R. PANDAS: horse or zebra? Neurology 2009; 73:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/25\">",
"      Perlmutter SJ, Leitman SF, Garvey MA, et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 1999; 354:1153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/26\">",
"      Tucker DM, Leckman JF, Scahill L, et al. A putative poststreptococcal case of OCD with chronic tic disorder, not otherwise specified. J Am Acad Child Adolesc Psychiatry 1996; 35:1684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/27\">",
"      Nicolson R, Swedo SE, Lenane M, et al. An open trial of plasma exchange in childhood-onset obsessive-compulsive disorder without poststreptococcal exacerbations. J Am Acad Child Adolesc Psychiatry 2000; 39:1313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/28\">",
"      Hoffman KL, Hornig M, Yaddanapudi K, et al. A murine model for neuropsychiatric disorders associated with group A beta-hemolytic streptococcal infection. J Neurosci 2004; 24:1780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/29\">",
"      Church AJ, Dale RC, Lees AJ, et al. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry 2003; 74:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/30\">",
"      Pavone P, Bianchini R, Parano E, et al. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr Neurol 2004; 30:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/31\">",
"      Singer HS, Hong JJ, Yoon DY, Williams PN. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 2005; 65:1701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/32\">",
"      Singer HS, Loiselle CR, Lee O, et al. Anti-basal ganglia antibodies in PANDAS. Mov Disord 2004; 19:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/33\">",
"      Morris CM, Pardo-Villamizar C, Gause CD, Singer HS. Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. J Neurol Sci 2009; 276:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/34\">",
"      Brilot F, Merheb V, Ding A, et al. Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome. Neurology 2011; 76:1508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/35\">",
"      Dale RC, Church AJ, Candler PM, et al. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 2006; 66:1612; author reply 1612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/36\">",
"      Rippel CA, Hong JJ, Yoon DY, et al. Methodologic factors affect the measurement of anti-basal ganglia antibodies. Ann Clin Lab Sci 2005; 35:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/37\">",
"      Singer HS, Gause C, Morris C, et al. Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Pediatrics 2008; 121:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/38\">",
"      Loiselle CR, Lee O, Moran TH, Singer HS. Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes. Mov Disord 2004; 19:390.",
"     </a>",
"    </li>",
"    <li>",
"     Pichichero M, Rochester General Hospital, 2011, personal communication.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/40\">",
"      Giuliano JD, Zimmerman A, Walkup JT, Singer HS. Prevalence of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection by history in a consecutive series of community referred children evaluated for tics. Ann Neurol 1998; 44:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/41\">",
"      Cardona F, Orefici G. Group A streptococcal infections and tic disorders in an Italian pediatric population. J Pediatr 2001; 138:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/42\">",
"      Johnson DR, Kurlan R, Leckman J, Kaplan EL. The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications. Clin Infect Dis 2010; 50:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/43\">",
"      Murphy TK, Storch EA, Lewin AB, et al. Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Pediatr 2012; 160:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/44\">",
"      Singer HS, Giuliano JD, Zimmerman AM, Walkup JT. Infection: a stimulus for tic disorders. Pediatr Neurol 2000; 22:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/45\">",
"      Pichichero ME. The PANDAS syndrome. Adv Exp Med Biol 2009; 634:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/46\">",
"      Swedo SE, Rapoport JL, Leonard H, et al. Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases. Arch Gen Psychiatry 1989; 46:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/47\">",
"      Leonard HL, Swedo SE, Lenane MC, et al. A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents. Arch Gen Psychiatry 1993; 50:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/48\">",
"      Perlmutter SJ, Garvey MA, Castellanos X, et al. A case of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Am J Psychiatry 1998; 155:1592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/49\">",
"      Bottas A, Richter MA. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Pediatr Infect Dis J 2002; 21:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/50\">",
"      Snider LA, Swedo SE. Pediatric obsessive-compulsive disorder. JAMA 2000; 284:3104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/51\">",
"      Zohar AH. The epidemiology of obsessive-compulsive disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am 1999; 8:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/52\">",
"      Snider LA, Seligman LD, Ketchen BR, et al. Tics and problem behaviors in schoolchildren: prevalence, characterization, and associations. Pediatrics 2002; 110:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/53\">",
"      Pichichero ME, Marsocci SM, Murphy ML, et al. Incidence of streptococcal carriers in private pediatric practice. Arch Pediatr Adolesc Med 1999; 153:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/54\">",
"      Murphy TK, Goodman WK, Ayoub EM, Voeller KK. On defining Sydenham's chorea: where do we draw the line? Biol Psychiatry 2000; 47:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/55\">",
"      Dale RC, Heyman I, Giovannoni G, Church AW. Incidence of anti-brain antibodies in children with obsessive-compulsive disorder. Br J Psychiatry 2005; 187:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/56\">",
"      Scolnick B. Pediatric autoimmune neuropsychiatric disorders associated with streptococcus. Pediatrics 2009; 123:e171; author reply e171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/57\">",
"      Garvey MA, Perlmutter SJ, Allen AJ, et al. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 1999; 45:1564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/29/37337/abstract/58\">",
"      Budman C, Coffey B, Dure L, et al. Regarding \"antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders\". Biol Psychiatry 2005; 58:917; author reply 918.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6031 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-201.77.166.39-5917900B73-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_29_37337=[""].join("\n");
var outline_f36_29_37337=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H28\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BACKGROUND",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Areas of agreement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Areas of controversy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Association with GAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Autoimmunity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H593033002\">",
"      Working diagnostic criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Clinical course",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Laboratory features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DIAGNOSTIC PROCESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Tic disorder or OCD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Sydenham chorea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      NATURAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Antibiotic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - GAS infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - PANDAS subgroup",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Neuropsychiatric therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Immune modulating therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Referral indications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      GAS infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Prophylactic therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/38/6758?source=related_link\">",
"      Antibiotic failure in the treatment of streptococcal tonsillopharyngitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/28/41417?source=related_link\">",
"      Approach to diagnosis of acute infectious pharyngitis in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/20/23879?source=related_link\">",
"      Clinical manifestations and diagnosis of acute rheumatic fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/30/27110?source=related_link\">",
"      Complications of streptococcal tonsillopharyngitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/8/8327?source=related_link\">",
"      Epidemiology and pathogenesis of acute rheumatic fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/31/39415?source=related_link\">",
"      Evaluation of sore throat in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/40/18058?source=related_link\">",
"      Hyperkinetic movement disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/31/22007?source=related_link\">",
"      Sydenham chorea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/8/22664?source=related_link\">",
"      Tourette syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/2/44070?source=related_link\">",
"      Treatment and prevention of acute rheumatic fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/38/2666?source=related_link\">",
"      Treatment and prevention of streptococcal tonsillopharyngitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_29_37338="Umbilical acanthosis nigricans";
var content_f36_29_37338=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F50592%7EDERM%2F63422%7EDERM%2F52056&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F50592%7EDERM%2F63422%7EDERM%2F52056&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Acanthosis nigricans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A hyperpigmented, velvety plaque is present on the umbilicus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Acanthosis nigricans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 377px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Verrucous changes are present on the lips.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Acanthosis nigricans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A hyperpigmented plaque with a verrucous surface is present on the nipple.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_29_37338=[""].join("\n");
var outline_f36_29_37338=null;
var title_f36_29_37339="HPV types in VAIN";
var content_f36_29_37339=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57576&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57576&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    HPV types in vaginal lesions",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Condyloma",
"       </td>",
"       <td class=\"subtitle1\">",
"        VAIN I",
"       </td>",
"       <td class=\"subtitle1\">",
"        VAIN II",
"       </td>",
"       <td class=\"subtitle1\">",
"        VAIN III",
"       </td>",
"       <td class=\"subtitle1\">",
"        Total",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Number of patients",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        53",
"       </td>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        88",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HPV positive (percent)",
"       </td>",
"       <td>",
"        17 (100)",
"       </td>",
"       <td>",
"        53 (100)",
"       </td>",
"       <td>",
"        15 (100)",
"       </td>",
"       <td>",
"        3 (100)",
"       </td>",
"       <td>",
"        88 (100)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HPV type 6 or 11",
"       </td>",
"       <td>",
"        17 (100)",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        17 (19)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HPV type 16 or 18",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        5 (9)",
"       </td>",
"       <td>",
"        1 (7)",
"       </td>",
"       <td>",
"        2 (67)",
"       </td>",
"       <td>",
"        8 (9)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other HPV types",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        48 (91)",
"       </td>",
"       <td>",
"        14 (93)",
"       </td>",
"       <td>",
"        1 (33)",
"       </td>",
"       <td>",
"        63 (72)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Sugase, M, Matsukura, T, Int J Cancer 1997; 72:412.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_29_37339=[""].join("\n");
var outline_f36_29_37339=null;
var title_f36_29_37340="ARV prophylaxis for women not needing treatment";
var content_f36_29_37340=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F51372&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F51372&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Antiretroviral prophylaxis options recommended for infants of HIV-infected women who do not need treatment for their own health",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Maternal AZT + infant ARV prophylaxis",
"        <br/>",
"        (Option A)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Maternal triple ARV prophylaxis",
"        <br/>",
"        (Option B)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Mother",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Mother",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"5\">",
"        <p>",
"         Antepartum twice-daily AZT starting from as early as 14 weeks of gestation and continued during pregnancy. At onset of labor, sd-NVP and initiation of twice daily AZT + 3TC for&nbsp;seven days postpartum.",
"        </p>",
"        <p>",
"         (Note: If maternal AZT was provided for more than&nbsp;four weeks antenatally, omission of the sd-NVP and AZT + 3TC tail can be considered; in this case, continue maternal AZT during labor and stop at delivery).",
"        </p>",
"       </td>",
"       <td class=\"sublist2_start\">",
"        Triple ARV prophylaxis starting from as early as 14 weeks of gestation and continued until delivery, or, if breastfeeding, continued until&nbsp;one week after all infant exposure to breast milk has ended.*&bull; Recommended regimens include:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        AZT + 3TC + LPV/r or",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        AZT + 3TC + ABC or",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        AZT + 3TC + EFV or",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        TDF + 3TC (or FTC) + EFV",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Infant",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Infant",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <em>",
"         For breastfeeding infants:",
"        </em>",
"        <br/>",
"        Daily NVP from birth for a minimum of&nbsp;four to&nbsp;six weeks, and until&nbsp;one week after all exposure to breast milk has ended.*",
"       </td>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        <em>",
"         Irrespective of mode of infant feeding:",
"        </em>",
"        <br/>",
"        Daily NVP or twice-daily AZT from birth until&nbsp;four to&nbsp;six weeks of age.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <em>",
"         Infants receiving replacement feeding only:",
"        </em>",
"        <br/>",
"        Daily NVP or sd-NVP + twice-daily AZT from birth until&nbsp;four to&nbsp;six weeks of age.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    AZT: zidovudine; 3TC: lamivudine; NVP: nevirapine; sd-NVP: single dose nevirapine; LPV/r: lopinavir/ritonavir; ABC: abacavir; EFV: efavirenz; TDF: tenofovir; FTC: emtricitabine.",
"    <div class=\"footnotes\">",
"     <p>",
"      * Exclusive breastfeeding is recommended for the first six months followed by breastfeeding&nbsp;with appropriate complementary feeding for another six months.",
"      <br>",
"       &bull; In countries that have the programmatic capacity, lifelong continuation of a maternal Option B antiretroviral regimen is another option.",
"       <br/>",
"      </br>",
"     </p>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access: Recommendations for a public health approach (2010 version). World Health Organization, Geneva 2010. Copyright &copy; 2010 WHO. Available at:",
"     <a href=\"file://whqlibdoc.who.int/publications/2010/9789241599818_eng.pdf\">",
"      file://whqlibdoc.who.int/publications/2010/9789241599818_eng.pdf",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_29_37340=[""].join("\n");
var outline_f36_29_37340=null;
var title_f36_29_37341="Decision tree example";
var content_f36_29_37341=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F64670&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F64670&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Evaluation of a simple decision tree",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 304px; height: 265px; background-image: url(data:image/gif;base64,R0lGODlhMAEJAcQAAP///4CAgH9/fwAAAEBAQMDAwPDw8DAwMNDQ0ODg4KCgoGBgYLCwsCAgIHBwcD8/PxAQEJCQkL+/v1BQUN/f38/Pzy8vL6+vrx8fH5+fn+/v729vb09PT19fX4+Pjw8PDyH5BAAAAAAALAAAAAAwAQkBAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIVSCCWIKIpEDgQOIwkGiSmMMAYTiAYRAQkpBSIFAaMKl54im50mqacOpTIIE5MJARGTJaOjngq5oC+WDAEKtyS0tgCxt46QUwiOkQoDJwnRRgQjBgwNvsjPJs7XMrUiBBHaxCQL0gABCwUFlisFBAEj5ecl9w2TBgfoJPFIENDUgEGEcCQGvCswqdy7UyyorQNQwEFFhKgKHhTBSSAVBQsQippIYuS3Vwki/yCbQICBCEctRXTqxIBATI8iaG0bARIjz5Ay+mUUscBliQgO1o06gUAlMqcjAtAbCqAoCQMNiBrlhcLniAILRDAIC2BfCZIACHAjwcBo25IB0IpAO1aEWQD+7FWZdzaFXAMQJgVwkOCAJLUAXGL1NIDeOWr58q3le4IyrlzCSgQLFW4pCZAAlDag929CAMABPVP2zFlmPREHuqKw6Jrc2tAEJvgicIDAK2zbCtxNaEL4Zdsyjabd61PuCOcLSjVISU9qvYsQQK1LACHC7eUCJ3ttXXwhPFy+Vr8WgYDApO0ADCxghu3Agd8kVHdeT3G/XrgBNEBKZLWldZsnwnmi4P8ByrHXwAEBhVZCP7d5hhhF643nhGVz+cVUQROw485DDEBooIQ5BdAbgfaIhwKHUWGGHzu+tCcTVOz0RkBjJXnlQGAneGYjOzgOOQ45JSTwzgHvxINQR2lFeGKMJqx4Akn9zAgAlAOFkiFzfUUFkXNp7STcLQgMFh+TKCbgiQFo+XQheRT9BmMo5sWjwG9AmkhLmL6oyRaDsZnAWp+I/AkAov+ZoOECpyAQG2AiKACKm/EBuVuDADjgKX3EoXLfZ6BImilPv2nIhAMHQNClAjv6NhcosDampQKFAoArbwz0kxub2/U2Kk7IEADBAcyw6ioiUr3UapcvJIAQrsiGgpb/UvbJAtB0VZFlTwOjVWofMwWsQy19YMl2AlfODjtVYby9MsG4JeC6Jn61yhqAqzYhMlWn9qUKkapmRMcDwUC40wUBEL2Q1xbpNrpGAlkd/AgSFEs5xXwzlPhPFQhw26lNhpRs8skop/zEeSq3TEcEw7kssxsXz2wzG9x9d/POY0SQK89Aj3EAf0EX3QUCA2hs9NJUNMv001k0gCPUVEdRAAQNV611E95s7fUSWHH69dhEMADkE2mqwoQkZJ8xQYhOLKBbiVoi90M2O7VdBmBiHxFyJBBQFCgAFC9Qj3yPGJBASK8UMNZANZGFONE66az3F/gsIShsorwmTT/e4VUK/wMhMzRBKVIlgAAEpZyOFygOED1lZZjVbvvtuOeu++683255yjUrwZqBnq2DmKnshVNAiMW7FvIoQEmWQgAPCGD99dhnr/323Hfv/fffPyB7yzkvAdoIWDd/omWU8aX+KAUw2aSjvwcgQBsCjN8yzGBDoMhGSCGc8RSDtfhwRzAqed9p/Mce+k3vfmzIH9D+lYRY8GYB/BhNUsSyohLZJAElOgAG2eG52kiKN/xpz7FAlR8IrkGCPEOa0vpgP/zpz2UqKlkNW6ABCpAgAwKQwAmAKMQlwBBoB5haIHa4AglUbwQC6IAELFBEKEqRika8ocuuljVAMFEFAniiCCzgw/8MbKAEZASAGUlwgSJK4AIAqAAHHgBHCnTgARyoAAAokAEJ3C+MeWTBEYHWtRd0rneITKQiF1k7ArhwBdZ7jgicGCZKjuACDxABHSlARg08QAIU0GMFMAAACXyAAwLwAAfiCEdIatFlWFHiCqzDyFra8pajcKQLItmhUmYyVJYcAQYoQAFSeqB6YbxfBu4oDUtmwAIZ0KMgX7nFs7lgeG34Ihhd+IFJrpIE3SzlN0fggQ5swAMAiKIE1kmBDXTAh838ZSk3gIFHomCQQZMbDLDJBm2mgJcA4AAcz7lHCAoUAAQlgQYwgAENlLKhIqgAHfcYz4g6FJPTZBrfXsDPNfj/8wQPYOgvK2CBBzzAoRJYB0lN6tASmHMEz3yABS4wygdsoKIAuEBJLSBNMFJTZmb7GAqwyYpPeGlAVvhoEIY5BHwWbQIsnB7R9CFUdchkRDNkglJ/sEwiODVo5WPB8LCiFRMgRSk/bcJWyfDVoMFMqMf5in8+ExbRkOYKax1DW4NGQan2qEDJe09O4sOxpNoTDXsFWgKSNssUdgZHKrIJj+SKV2SC77KYzaxmsyc+reVQBdhkVAFmtI5ARdVquEytanX3u6INDRl9w+a5ZNIcmWQLrpdbGtKS8jMq5fa3MLjaAIbbxY4C97hHGa5ylWhc5Dq3H8odQG9J6NySpc0o/wjDlClOYIAdKTdrza0uH6TCALDUg0yoCm5fS6CO4c4ovOLNw9+wEZrI5YRxeFpJOQi7Xnb0Nx3DhZtv4+vFqA6gddIxHeo60QAEbOJ1nZIdfCMwXHTAl8B24Cdah7Q8EgbQQdDzyoWjgZ8LY5gOChCwJEnYvmtg5ivyY1l+fno+wJ6YD4DxBQhRtBQgjQN+FXMwA5FhqLRaOK03jkMsdKSd2oRwhEuJbIhO+FqBgAthV1kABIYLgREmmcCriy6Xs/rlsQFGzMqNWZl/Gxc0KxfJa6ZaA9yc5jjn4ZCrvSWdo2tnPNAyz7bc83f7nGE4A0HQwyV0oaEw5z1XTNFzMP/xENpMZ0NDegySFgJW6KzmS7sh00IIs5iH7Ok4gFrTWuayl0ttaktPmj9FrVcvMIRUVmvh1EQYHlXz4Z0CeKId87P1rV0tBNaQtSqcmhN1hc0FXL+assu2R29eEaC7MhsLzi72etSTJMIxiHCEPe21o5DtILDGSLKMdn/GjVdim5s/om0cOVxiWnYn1d1AGN5s/SuCeVUrRwfQlr2bhu8flHvg2C64D8qdti4WwQC86Bu7D25wYsvNccNy4A8i4J3/jpviC3f1fAkXuHfIhHANMBx/HaA4/FLkcQiwL3/1d6eJK7wHzt7c65oHOlCMinTbwATqGLY6BEM4dkHyVgn/8AzoptuytR69OQ9yzh+1qO94ueIw80pIwue1wyshgyv1Nkv2spv9ep2lA8hx7uoaL4oWXEcM+5TnYq7DL8bxCJnG8iqGxEa9Cs5GDUeuEcDFzjtTbzogkZaNVsETeQR6B+1hz+B3Nax96sS2oAgz+Ih1eDAxOgKhfaBs93pQueqjIVmQJm+Gyqfh8juAvWFtWAfZ58D2TWO9CXo4Agp4QAA9/WEQmeB6NOD+BseXAt996cINZOACGKiiCNSJRSUU/wzJr0H2obD8ZJoAoGMs4xkv6UY4ynGidsSjHvnox3SqP6Nql3rsq+P0+ttSly0AvyYzUEl55vSXm9RJnxRK/3FESqaESqrESvAXafKnA0xnfxCISPgnSPaUAf7XS8EkAsNUTABwTNbzRMv0ADj1TNGUfw2YBdtnCMuXTo/0TC0FTt5UAuVEUOrETu4ET740AhJAT7oHRSeYcLm1ggDlgr1nUAOFTgrFUCgFUXGEfjhVARd1gSdwfWaQgoWwfCGFAb80ACVlU6WkUl34giPwUiIQUzNVUzeVgzm1U8F3Tz/YbkHYgz7AVEJAhWVghYSwgjnQVU31hvcWh7QXf4AYQX4IeIWoQ3LYd4c4BXg4CGN3dpAYid6TdgyYWw8YgZhoO1BneYuIcF7UiZ7oB40YinaAZzZRO5tIiidDaZWmiv88w4puBoqu+GmIJouz2E+1eIs2A4toZou6+Hq5+Is4FIzCqDK8KGa+WIx3SIzKuIrM2Iw69IzQWAimSH/wM404lIxD0HBgwwt1Y3NrcHF00xWpOAMcBxbidm2juI2Pxh2Cc3KFczghwXKLIysvFxIxRwCSExL6wwAqNnDrWGygwiQ8l0Q+NzqlI3T+pTqsAwCuwyZIhwuZ8CKZWJG4U47Yp435VnWd00tYB3nKs3W9NApeFz0l4SlDZVmSuJIrSYlyEJBB4HbpE3egMHetoUDxsxBSQiZ66AV2SAYwCQSOB0CQYHhpQUCJ52MJVHqOZwnp8Wi4kIhh8JOYppFAoHn/I4QVncdB1+BBDPNkglF6yCAs/BFZJrJ6gViJl9OTXUCVYhCUNCSVI6ABv9eGAECXAuBDTuCWYQCX4yWXd4kBz1d9I/AAHgB9Ymh9VpkEfrkHejhF0/dICyUCHdBKIuABelmCmBRI6ceZffRH77dLi4kEjUk7FnmatjOBLWBSmKSXk/RL4LcB96MBH6ABF8ABPdRQBDhKpXRKqbRKFWCZC/iSoxkk1oiap6maK6ABArUBPEUClgR+HNhVHNAB1hN9asRMakiCdulTtVecRWZqgOkB43ebJCBR04eEI8ABz6RHhrlOEqABNyghwbSD9fQCfAkGpRmecKCHFniZHVBK//wHALUJAM8JnVo4fd/UQ06ohlD4f/gJnkWwn3GFDZzQRbxwjboSABjJmICJUCWFm+5XhhZgAeNXAhhgmc4pU6GkhWloSTolU93pht9piLyWOfbQa7/mDmwye0PAgUaQn19AoTN2FRVjFeFBAoahK+noBGw5Ax0woEUgpF5ApAO2buqWFtPWSzXHfR/alhKaa2F6pdxWDN7mEqWFZZrzpVxApV1gpTaGbkNVD4FDEf+ofGy6BW7abGNqY4syCSYyWqFweBPgEg6Qbk/wiCy5qJDokq1mo59BL/zmkJJ6Qu5xBZeInBDYoXfYp1mKjXBIcKC6BXD6qaMqqqh6qqHKiP+eqqpXigyjgF0roF0uEAzDMKeuuqr+VV4qh16V8o2VYRGFVKS5CqnIAJXvIXP12DilwhIqMTkeEiStmqusoXNzYXRB5zq60GAPBpHjYxzSWqzGqmHOE5IeRh8l6RUUgqviyqo8cado1WIkxBo5GWz1AaylWqzGlh05gaa1oZQsFmRNeRUZF67tqnwpNC820WTUBZbUJWVjiUL5wS/QEhWNNgACcrCJKqHQhWYPo7HCI6EHsGfTBbITCp7HGF3TOo37ebGcZrKMeZyaOgqIlmgwewSZqqk166s3+wY727N44LJuBpVAG2nSWLRxMLJ0VrJICwcdK2Yf27RywHHscLH/GSu1c4AJ1jRWF2oCGcqhlQK2WMsFwqV0umYOauYQviYiOTm2tzZoA3ZsSNoiSroLTeq2TdBdyuUT9DpX0maPaYq3e7FlysUpfeunC+KvWCq4UUBh0UW00San4VqnHca4UaC3yqUlwxNvg3qUDmmoiGq5SXBmA2BNV7pvTuNvzGCpuCW6SPA2CgABp5WvrisOZoEADsdwuuAEtIq3VzND2SaOBZukQbA6Kwtp3AGsr+oCI+eOJscOKKdyiEOPLuc4+Chz0DohInS8hNYPd+un1zSQHSkhPSc6iZGQ2kp0DfmQsANrA2FcOTuzTcepKWOSjTUDuja+xlMqWWeuCpSu/+mwYCnJqARsdo7qVp3GrjEgk3DnkTUpEnTHeK5RrzK2KDYBLnXzpHrKvWDwuxzlakNJeEU5QIhnQACrQAPLn4aSp1qwp3+QvPuUeSyxefGhQZ7XQaHnsAoUsVVWoVGZlkDjvTFAuzqgwS3MwV2wAEwLWkisfXLJe5N0PVIKU8OXRUUTu62rwJ8mlU7kQjXYhtQnfUfgwnsgQ/jbxDTQfWLEgiiQRmtEfpNkfnNUR3fkme0HSDNKAmScB4ChvKAls/ILgcr5T16shQKQmOuQgRgFAAFIAZ4ESqJkgL6ZgME5nDYjQjUQv4HcdIN8Ty7kQxpAhiuWgQCwgcaETCConf/OBE15rMdobAVKvIpyqX9qOALhJAHjBKA0KEU2+E70KU/2mYh7bAdYLMu75EJFJABnRAFGiFDqKQILBVESwIQSVUdPGIWW3DJmbMwskIWwWaIimlIRFYYmIMpmSFMuilMxeqDeOTOAEbpLxMI0QIdBMMxzoI/GKM8ywId1+MpRwCpZHM9AnDKx63AqqM9XYM9vsDr0+5cDbTKxJDOKWsAUfVkHXDL4LDOavMmp1dB5ANC1KwcFHdJKBgESR9Jo0A/+jNIw8DYs/QYqEtAvHQZmQ2YzDQaKc9M6vdM83dM+/dOim3emmRlDsAyR8A8R8rWcigma0LWypqG80KHG0EX/xjAJyTADrhC233FIKFELMg0QX5ELtyK2CkAfNuHHaNM1EpF09hoECIE33AAOJ6C2Bj09TrFrAqGjbNujLBA/DKAAMRM2G7El+pPTlQE3wMbXVzU/gq2m7NE1wFbBe+0LuhHWWtATYe0cHYUAKKESFmQUMGEUMwFCNpFskRAg3IDZGhcDQlHDZUW8sGG3AOEUTZEfzKBsdVEWtxC1lj3Xp7CkZe3DuT0cBnAa8WHcP4EQxgXczCAtvZ0FMKLZo4HcqOBjhGEY3QUKisEtjREAjzEjcuIijrKllyHWmvEaZfq3rxC4JGAajpcTKVcTcXUh3k073IUQ7G2xd2Uha7ER//u1dMo93f+Q35eKIRBTWybwJoU1AgYzHQeRS9fhCPy6Hd3xHeH9Vwl+pkuXJ+hBHtiUuCgCI/0wvLHwOEdmN6JwGfyoNl6yYjCi4JDA3+yFycWBEDAOKMqdHhwc3SoAIyHjj2xLIiaCGBNBC1YiMbOzuAYbI+adHzXyWLhKuXf6I6UB2jjCJYqQ4iVRABEwIuig5YsSCnfaGliuGQpRGV4BI1IeFTp+4GEiEwgiE1FFAGZyF2kCCeu6HW8SJ9IDbXXSuTfxFRz+GXwCqImC3oQKuppBKOz1Gq5jKWN5Kr9q3wnuLYXaKU6hCvVmKpRSDNsgMhhOEXIO55+L6Qx+CrRgfgXK8iqxst6goCIB9zH2Ii684ivzwrDwMrwIoUL/turMEg6qGwPOLS7/Vi79Vqk6gg4h4wkLoHSY0Bu3/RqsknEMQ+lVgibJPisAJ3DTjh/94BK4gg6+vu23cOasKyrPLQcGswOOzQMKsxdK5wLsQqp2stIzQDE9YBPfywMZQwXLPgPDawWzrqX2DtQGf/AIn/AKv/AM3/AO//AQH/ESP/EUX/EWf/EYn/Eav/Ec3/ESHwIAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The expected value of any node is simply the probability-weighted average of the outcomes across all of the branches of the node. This is calculated by taking the sum of each branch's value times its probability. For Choice 1 above, the average life expectancy of a cohort of patients undergoing that therapy would consist of the combination of 45 percent who lived 10 years and 55 percent who lived 12 years, for an average of 11.1 years.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_29_37341=[""].join("\n");
var outline_f36_29_37341=null;
var title_f36_29_37342="Metacarpal neck fx healing";
var content_f36_29_37342=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F73161&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F73161&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Healing 5th metacarpal neck fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 352px; height: 262px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEGAWADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5iUjaKdTU+6KWgBafGe1R/jSpwaBGhaS+XKrdga6JsSQh1rlUPArf0affGYmPIqosiSLCDOVrIvovKlzjg1rE+W+R1FMvohcQlkwGHOKGJPUwWqM/SpXGDzUZ+tSWREHNOjGWFLinxjHNAyZeDzW3o3/HvNnuQKxF5ra08hLI+rGmiGSTMKOPLz71HKec05OUI6UxAw3Rsp7jissgg+4rTPXGc1UuY9sp9+aLAisBV/T48uSD0qmg+atLSmVZwH6Gkhsv7Gzwc+1SGB8khR0rYt7e3DK8r/LntWj9o00cbAD7r1qtCbnItE6gkVCEJOM/pXVTx2M6HygoPtWTcWhjf5T8h4GBQFzMvIP9HPzc9axiK6TUVEFkS3334UVzzDngUhoYBVywTdcKMVAq9PSrNu3lSqx6DsKLA2a0Vsz9FJ+lWf7MlPzeU2Kda6siqBFC2fpmria1MmcqCD6rTuBkzWLxAZ3Lj1FVvLIbPNdPHqUN2vlzIFLd6oXtntYGMkr70BcxJUOcg1hXalZGHvXTzoI3Jc8Aetczet5szuOATSZSKEh4NVqsy9DUEab5AuetSUN7UVqnSGwCG681MmjESqC3FAGTGtToOK3RpkYYrjtT7zTY4rZmX73agDGhiL5POKlCEHA4Hc1YtyvkqoxnvViK1eQcAH2ppElHGTVi3izMM9BVh7J4sFlOevSliXCsxGCRimFjj0+6KdkUiZ2jjtS96ksKWkpe9AiWM8Vf0+XyrhT68VmocGrKHBz6UCZ0t0MEHsRmoVfAojkE1ksn8S8God5/CrM7FbUYQCJVGA3X61QI68VtECSNlccH9Kypomjcqe1JlR7MgxT1BFG3NPAqSiSMc/Ste3X90q8YHWsuLk5xW5YoJQOnT+lUiG+w14mI9aYI2HUVsQWGUBaRQKc1lCFP70E/Qf40xcxiiM7hnFJfR/ug2OAcVqTWgAyjZ/DFVNRwsCRfxE5PtRoFzJRRk1YhUlsLw1MC9/WtDTIRJPyOKENly0tX2gvIxz2Bq0IBjvk+pq2qBUAwRzwaVVBY4xgUCKLW8qLvjYH2NQ/2u6gpJCGI75rXETEdqw9SiBcsByOvvQIpXtw104ZhgDoKqFcn9anK0gX2oHcYqjFWLWLzJkTHU00LzjFbGi2bSMZMdOlANl+KFIxgKAB6ClKDnNTsp3bQOhx9aQqQu3GMn9PWncRnXMGRmP5XFUTqs8atFIqnHGe4rb2gnpzWFrMCpKZE6HqKQzLurhpCeoB7ZrPlPH0q3J34qpN1pMpFKU+tV1Yq4I6irE1Vc81JaNAalMBgHpxUi6pOxBzWXmpY6ANVdSlJz3qR76WQYJ4xis6OrcCkmmJsntoyTnoDW1YQHcDn8ao26diOK1rJZPl285oEaRtzIg8l88chhWbqFr5cbPjB9Ks3NpcRjzIZMZ7Z6Vi319cFWjlPPQ8c02ykji0+6PpTqav3RTv5VIBQKKKAFFWUPSqtTRHIoEzZ0mT53hb7rj9aeQVJBrOgYxyK46g5rZuAC25P4hmqM5EOfTvTJUEowfvdjTwDgAUhpBcz2QqxBGDSqvSr7R+aOR071C0JR8HGcUWHzDYx81XbaV4SCnWq6JzV6xjDOOnFNITLQa4lGXO3v60fZnYf6xs1cReCPSplQbetMkynW4gGQ7bfY1WO52JY5NdA9tvib09Kx5I9rcd6VgTK23kcV0Oh2nKZ6kE1ixIDKoPc11OkcOx7BSBTQXHyIA+3PC8Dn3piKNxI4GSMU+Vgjc88VWdskk8D2oDc0bSIMuMjcewrG1CAo7qwwQelaem3KwzDPU8dKk16JWVZtvJGD9aAOTjh3nBOKe9qFXcGFKMB2x605gNvSkMjtYhJMoJ6112mRCGzaQnrwK5iwGbhcfWuuiTZaQqf7uTTEUXLZJGME+lIJWD84JWm3MinKgkDNU8qxyGO7+dAGjC6vLsYgZrJ1+AxSFW/iHFWoGzOr989TS+LCpSHC4Yd+9AzjJR1/Oqc1XJhyTVObOe1Syijcd6q1ZnOSar45pFoQZyMVYQVCgy30qwi4FA2SxjnNXbfpj3qog54q3bAmRfegh6mpZgkgEVuwfuF+YHcfWs20ixkntWrdEPsfHJAH41QImlnMkXzYAx0rjtdmxPhTzit/UZTEjbegFcheSea7P69KRRjKflH0p9NToPpTutIYg6UtFLQAVJCeeKjp8Z+agC3HnitaJt8CeoFZMZrVscFcH1pozkSLGWbjvUy2pODyTWjZWvmtksFUDJqae+gh/dwJkjjjrVEehRS0dBnacetVdQRRIoUdBVyW+uHHEe0euMmqTlpGLMcmkBCgrV0qHcxY9OKoKuK1tMOI8Y70xstsojkYZ6dqkTHGB9c05uSX6d6ifII5wKBGtZLHJFIjAbscYrndQhMUjqw+YHBNaVq7BhgmqeqSeZMx/OgDMj/ANav1FdLYDDkZ4aucUfvF4PWulijKsG6YwaAeoXg2tgde4qrjI5qzdcyn0P60wRkpwOc/pSAIUIII5NS6zKVtYlY1d0y082QIfu9axNfuRdajIIxiGI7UA9u9MDOQZbNPb9KahI6UEkn60hljSI99ycdhXTTnEMQGcBdp5rI8NwktO+OgArTdiQQelMRQdcj3qPyMj0ParhQt/SpUgzz3H6UDKUEe1vm+7iqHiSbcYkxztya6UrEsZkdcheeelcTqM7XNzJKxzuPFAGXIOtVZRxV+ROM1UmXg0hoy5l+aoQozVuVTmqxGDUmiFjTnpVlE4qKIcVYTigBVXvVzT08y6Qe9Vh+tbPh+DdKZCOBTJZtBQihcD1qaJGnlRB0BqpNKN525xnr61paNwJJW/hWqJ1MLxdMEdbaPr1b3rlXHXFaeszm41CZ85GcCs5xgfhUyeppEyF6D6U6mr0FOFIYtH4UmaM0AL/KnJ96milT7woAvRds1etiUIINUY+1XoOaZDNKKaV1EaMVB6mr1pAoPTv371BpUHmScjjGK24bdUPP61SM2RrACSAOKo3tsN5IGDXQxIARlM5689qi1GBTGXUAAdsUCOVCkZrQ0xSxdfbNQzoA+cdetW9HXNywx1U0gNCMBoeOo65qvImWB5q/FHwcCho+Md6bGg022DeZIeEjUsTWFPJ5sjFfu5rqdQAsvDEoHElywXPt3rk1FADFHzjHriusnjKxK2OqiuXjH71fqK7aWPdbRt/s0AY0gHmDNWYIywzioZYwJQOTzWlYRF5EQd6ALFy/2HRpZ+kjjatcUFJyT3rq/GcoUwWqH5VGTXOIoApMa1KpUg0uDmpyg60LGCcdqQM6PwrBusLlsc5qR4skjFaPg+AHSbg+5pki7GPFUIpxwgDn8qdtywwKnCbjgdMVLFHjceOKAMPXZvIs/KHDPxXKumc4rd1mT7RdtjovArNMWR05oGkZciHvVSZRzmtWaMnNUJ4utILGRKvJxUGwsDx0q/MvUAc0kMGFOTyak02KcWamXrQ8RVzjpUiJ6igLixoXYAdSa6eILZWKxDHmOOfasvS7bawmcdPug96szOWckmmkTcfuJYAZrcjf7PoUsmcE1gwklwa19dfydGhi6F8ZFFxpHIOMknuaqzcZ9KtynGazbqUDNSaGav3RTu1NX7o+lL2piFxS0UZ96ADrSr94UlKMA0AXoh0xWlaLkj0rOg7Vq2Qy45pozkzpNLjCwZHU9a14Y9yqeKztMX/Rj7NjrW5aJuQEYBHY1RAkSfLxgYonR2hcYyD2q8lu0wCxpluuBT5YFjs1eTiR+QnoBQK5xN4g3cdM1NowH25PpimX6MJ23jHpT9MOy8iPfNCYze8sIzAeuBTkiBYA9asTphwQOCKktV3TLn1oEUvGC7LOyhAxjnFcwq+1dV425mg9hXNAc0DIY1AkHswrvNmbCM+1cN3+leg2qeZpSN6AUIDCaP8A0gHHStvRYQZt+OF5zVIxAy89q3NNj2QOcY+WmBxviR/N1VvYVnKvGauar82ozH3qvjipZUSFhzUsadTQFDHmrEaYWkB3Pg+LbokjY5INUJhlzxW74fi8rQWGMfJWSyZkye9X0JuQJHzxSaq4tbFv7zDA+taNtFlgew5rnPE0/mXCxKeF5pDuc+wJJphXirG0Z9aYw6jFAIoyqKpSxljgCtYw55PPtTHiwOlIpNGNJaqFPHNVzGVzxWzKmR9KqsgxgigGzNlUFQQOaktbfeQzfdq4tiZFLKPlHWhDtwB0FFgbJmIjUetV2bcen41I53H0pmOc0BctWUW6VdvIzTvFkxN0kQPCLTrA7Z4/QGsvxBN5moTn3xUlox7qYIPesiVyxNWbtvmNVSMjikMjX7opwpq9B9KdTAKMc0UfjQAveik70ZoA0LXoK1rIhZV54rHtj8orUtuoxVIzkdroqBoH9d3FbdvEd3PAzyfSsHw24chQR1zXSyD5hs4qjM3dKKhh5SYOMbj3rI1SMi9zztA/IVb0icCZVJwAabq+1ZpN2fm6cUMRw2pnzLtsdBUNsdsyEdmFbGh6Df8AibXf7N0eJZrxwzhGkVAQvXknFdWvwX8cg/8AIKh6/wDP3F/8VUlJO2hS2CS2RhTrRMTrj1q9Hpd9p8C2+q2dxZ3BQOI54yjbemcH3BqvbrtmFUIyfGi/voa5srkDFdT4yT97FXOFO+aQIrlK9C0T5tGU9fkrgiK9B8NfNoo9kpoGUfLxOa2IxsspDzyMVRCDzPTmtK4+XTsfjQB51dnddyt/tGmY4qWZcyufVs01Qc1JewIvIqzEu51Xrk4pqJ7Vc0+PffQqB1YUAz0K0TytFx6gCsgRb39u1dBcJt06NSMcVmxRkuMetXYzI5UFtZu3c1wF5J5tzI/9413HiqfyLEoODjFcIeaTKRHjP0pAuD71Ljj1FGKQ0Ruv1qMpgVYblRntx9KjI4pDRTZMk8VUmj5JrU8vPSq1xHjIIoGXLe1zZLjpjJ96z/sOHJYcmrmn6gttEscsbMB0YGrUGrwq/FuzrmhPQLGMdNc5KnHOCKie2kibleldxaXtldLhoShznbjkU3ULK2miJtiC3fH+FPQDiYTtlQnsRWBqb7rmY+rGup1GEQ72YhdorjrltzsT0JqWWjLuQc1Ggqa4xmowOKQysvQU4U1egp2DQAcUuaQUUALQaSl/CgC7a9BWpBjArKtTwK1IM4FNGcjotDuRDcJnjng/0ruWdQVYc5HavNoOCp6V3OkzG505D/Eo65q7GZftXP2jcAQKta6fkjlHpVCIkMDn2rRvR52n57igDkdIv7jSdZtdRtG23NrMJkOAeQfcEdMjpX2X4f8AF2m6x4OTxGH8iyWFpZwx3mDaMuG256Yz64xxXxbMNszD3rTsdavrXRb/AEm3mC2F80bzx7ASxQ5XB6jn061LRUZWPoXx34Qu9eu7jxHomow6nayoNsMbbtioAuIyCQ3Ickcc56k15PLA8N28cqMkiOVdGGCp9COxo+GHiXUdAvJTp05VX2+ZE/KOAc4I/Pkc8n1r2A6j4Z8dfZ7bWlNhrQXy0kQ7ckk8KehHGcN0z3NPYbtI8O8YJxEetcuw4r1b4qeCdU0O0e6aH7Rp0RybiPkIucAuO3X3H0ry0gFcjvQTaxXK5zmu/wDCADaOB14Irg2XBIrvfBIzpnHvTQg2YnxVy9AFjjHaomH+kHPrU+or/oPpxQM89kHzt9aRFz7VI4y5wO9PRRnGagsVBgZrT8OxeZqkXcDms/HFdH4Nt996z44AAppEs6++UiBFz2qvYxnLM3bvV3UPlAX0FMiTy7NnzWhBxXjCbfKkY55ya5ph61qa9KZdRkP93iswqQallIYce9AB25xxnGadjNAGBSGMx1PrQRmnkUhXmkNBAFAIbg1BOA8gUc81Lg9adbY84bsc0IYsWnDBL9qI7Q+ZhB0OK1reFdw3DK4y2elXojbBRkACmK5iiNkIyPeq19KYxujJDDnitm7CNllIK9sVkXwDcY5oHc5PWb43K7AMDqfeudm6/wBK3NZiEc+R0bmsOfrUspFCf71IvSib71RhsUiiuPuinA+tNX7opRQAuaBR2ooAKWk6UUAXLY8CtaCsi14ArWtz0FNGcnY0YCBj0rrPCcvzPEfrXJxkcHFbWiTmG9jb+EnBq0RZnXPHtk4Bxmr9ud8TKenWoJVyoYfWpIGKkZoJOV1aHyr+RRwOtV0rd8T22HjmUexNYqjNIZr+Gn8vUkAP3gRXcXkfMbqSDgGvPtOk8q7hccYYc16Nc/NaRMOmKpCOh034gX3h2yVb2I6npzKFaGRvmVe+0nr9DTNT8E+GfHtlcat4JvUtdWdTNLpzuAvmHnaV/gPyv04yc9K5W/QXOkyr1KiuMsbq502+gvbCZ7e7gbdHKhwVP+e3Q1LRal0Y/wARaBqfh++NprNpJazc7dw+VwCRuU9xkV1XgZSbA/jVbxX491bxRoNnpusRWsj20nmC6VMSONoAB7DnJJHXI4GOdLwTHt00k+maEJoCmbk5HeptWUCxH+6aazZuDnoKsavGTZD/AHaYHnAHzsT61KozSldrN9aeg46cVFixortvBFuPJaQjqSelcci7mr0vw3afZtMVmAztq4ozbHX2WnP1o1E+VYgDrt61IFMlyMdSag8UyeVZsvoM1YjzK7YvcSEnqx5qAjjFTuMnPqajI5qChhGKCOad9aXHNIdyIjnrSGnmmtikNMiYkfSi2G67iB7sBQ/Q1o+GLBr3U0OBsj5OTQDZvW9kP7MlZs5LhefSsWZ9gO7jsBXW6zIIYDCoGRxgVx80YMgLcnrVPQEyMsCQc54xgVTuCQ5GeKndxn0A9KpzOgyeRSY7HOeIyFkjA9DXN3DcmtvXrhJZlEfIUYOa56dutSykVZDljUbE4pzc5pjdDSKIhjaPpTsUi9Bx2pw+nFACUtA6UtACYoxRil4oAntzzWrbnOKx4D81atqenrQTI1YOg9K0bbhge4rNtzx6VowHkdKoyPQdPk8+wifOcjmpEXANZfhebfbPCTyOQK1GyGyOh61Qh1/CLvT2UYLAcVyewqxB6111tJiTnoaydcs/Jm82MfIx59qTAzol5zXogbfo1u3fivPoh6Cu+yU0m0Q9xmhDYtudwZP7wIritRh8i6dMHqa6+3b5uOxrH8RQAy+ao69aGBz6oa9H8LQiPTDn+7XCWkJluFHYda9BsBs0rIGM8YoQ2Zsh2zk54zWtfL5unZznIzWHIcuea2rAmXT2jzkqDQDOAnTE0g7bjTduBV3U4/LvJAR3qtjNJDbLOkW5ub+GNRkZ5r0uQiC2CdOMHH+fauZ8D2O5pbtx8q/KDWxqM/mysFPyjpVruQyxpwD3AJ9ayvGsm2BwM8jFa2knEgJ9KwPHL8BfWn0BbnEsPSmEdalfrTDUDZGBn/Ggin4pr89qBkZpjfWpG/Wom9MUhoYwJwB1Neg+GrBdK0g3EoHmPyBjqawfCWjG9uRcTLiBDkZ710mt36bfJixsUYFOK6i8jEv5y+WJOWNY94GUELyfQVoStjczc44AqpDAZ5xkHFDKRlyQu6bQCB3rmdavljZoYX3MOGYdB7CtvxdqqW4aztT8/wDG4rg5pCSal6FIinkySaz5m3H2qaeTPAqqRmpKGEUjDinYpD0pgQrnaKcKaucD6U4UALxSUtAoAKPej8aUZoAdGcMK0rVqyx1FX7ZuRQJo27Y1ow9v51lWx6VpW/PAFUu5k9DpfDU3l36j+FxiunlPPfrXE6axS5ibP8Qrsll3DPemIUZXB96ueWl3bGFxyRwapAjp1NXbQkYOcdxTAxIrF47xYXHfqfSulmk3tsU/KgAGfari2sc0JLffH3Wx0rOaLySM5YevrRawEtvwxBzkc/Wn3luLi1cd8Y+lIAu3cucdqngbJIbjPOKAMKxg8lm3qM5xXYyqv9nKUH8NYV3BtdMZw1dJGoOmGMHLhe570kNnOCNs5bg1r6Rlfuk5zgiqjRlm+YZrT0yNQ5Kjlf1700DOd8WWwS4EsYwDwR71i2sDyyrFGNzscCup8XKESKI4D9cD06VY8EaSWkF665C/dz0otqK+huR2w0vRYraP/Wbfmx3JrFmcKvJy/fFbWs3hdSI/u5zn1rmncs20Dp7dabEkbOmSHfnNYfjckyRn1rQtn24Udc9aoeL/AN5BbP6Eg0X0HbU5Fs+1RsDmpGzmm96kY001hUhHFMagCJu9X9C0mTVLoA8Qry7H+VJpWmy6lciOIEL/ABN2ArqLyeLTrQWNngY4dx1NCQX7DtQv4rS3W1ssBFGCR3rCaRpGznk0yRi7UgUluO9O40iWNCxUFCxY4C1S8T6pHo9mYIcG6cY4/hHrWnf3kej6cZ5TmTGFHevKdVvZLy5knmJLMc/Slew0ildSs7sWYlic5Pesud8ZFWJ36k1nsxY5rNmiGtzzTOKfTTQAw/SmnpTzTD0pjIF+6KdQv3RS96BBRS80UAFFFFABVu1bpVWpYDg4oA27ds4rVtj04rEtXrYtW4qkZvc1rZiGUjtXWWblo89sVyNseldRok6lfLcDIpog0QORVyCN3UZOR/nioJoxHgjoelXbQllB6UwNWyciNVb7v15qW5tkeMjgZPpUUEJcZBxjrTyrQp8zgj69KYim8OI23AA5496IziQE4xUzMXUn+E8niqD/ACHNSykaM22W6tVA46mtSNjGVA+6D83HbFc1DcMk6uykqOOO1bVtdQzbQJtrHs3FCYMfcR7rlRsx0wT3q/YoEwwAIz168CpYbdpQTINwxgbW6elaDxi1shlcMM8+9UkI47Wbc3ep4GSC2OtdJZulparGuQAMH0+gqpFAViaZh8xPFK0ZdURWz8vJz3oWmotypOxblicuckVSEQd8qcVoTwOnPXIqlJg4VW2n0IpMpEoQxocc9gf51S1tfN0xuuVO4fSr0mVVI+oHOabeoDZAcDjqaAOHYYNMA5NST4Dtt6ZpbeN5mwi/iegpAQuAF5/Wr2k6PNfyBm/dwDkseM1esrCJGDzYkI7dqtXd8Qnlx/Kg4pgWp7i3063NrZBV9WHeuflkLuWY5pJJCck/WoNxZuaLhsSKSDmr1uqwwNc3BCxKM896ZYWvmsXkOEUZJNcz4u1oXMn2W2OLdODjvQNamN4n1d9Su2bJES8Kv9a5i5k61bun61kXUnUCobNEQTNubFR0fzpc1JQhHtTGFSdqaaAIjUbHipWqJulMRGo+UfSlHvQvQfSndqAEpaO9AHFABRSgUYoAQU5ThqO1JQBpWzcitm0YYHpXP2zdK2rNuBTRnJG9anpxWtbMVIYZBrFszyOa2LfFMg6GyuTchI2A3D9a3rEKvLdvSuV0yQJOPeuqsWR5OR+tUgNaBZphtiXCevetjS/DyXB3Tz/L3PWqNnKACFGepHt+FaNvqMgKon8POapWJNafwzbzabcfZ2wUHynHJNcLd6bJC53HK5r1KwvVOkXbTRIqtHkso9f61yV1HDOkkgy0YwAOhIokgi2c7a2mASwyKnksISOhB+laVuYlZBwc9FI4FWiu77ywxqTxtBOPrUpFNmZY2rKQIrh4z254q7dyXioq3L7kByD6ir32MA5BTDcD1qK/tpfs5ALMuMg07aCK7XUTIFUgjqMd6qM8/PlRgZ603w9ZGW5aPPO7mu4g0yKOPa20HgE01dibscHK9yW/eOF9KropZix5bPOK7TVrCLZnbGQeMLzn8e1cve2ptZEliO6Njggc4pNMaY6K2LpukJwegxzVHW4H8gRQ5JbjArVaf5AFzz3FWbaJTErlef1p2Fc4eHR/mzcsAey1IbbyyVUfKD6cVt3sB+0nePwqCbaEMDJtI68UrDuY0zEZAPFUZJCScj860LqIox24YVlzgfNjt2pFEEj4PrT7aFpJVUA81Fj5unParr3K2Fk9w2MgYUe9ICn4r1VbK1FjanDkfvGFeeXMnWrmoXTzzySyHLMcmsW6k96GUiC4m681myPvbmnXMmehquDUGiJKWmZp4Oe1IBTTe9PppBoGQP8ASozUr9ajPegQxR8o57U4ClUfKPpSgUxCY5oxTsUc0ANxQBS4pcUAJikp2KKAHQnDVs2TdKxR1BxWrZtnBpomR0VmeRW3bnIFc/YnOM9K3rNSwG386ohmjDxyD0rb0+5fK88+oqjaWoxlzx7VqxaccboT05NNCubtlhgGDEHpmuv0zTlu/LkEqKAPnU5ridHmAk8mUlGPHPeuxtCYkVg3HcetUhM2tRAS1+zwyDyRw2DxXOB/LEynlautL5j/AC8AnqP51lagQh3DjdkYoYIs25/iLA57AcmpVMXmEBWBPQg5qjp552AFmPOM0pmcPtRdpzjIpXDc0ERJXZQWG3BPNWZZykOwgsoXGDS6XEoA80Fj97jqfasjVL13uJVBAUHAX09qewJXJ9BYQar0ADHH0rpdZlcRRtghSxBxyDXnst+9pKHjAbBGQa6WHxLZ3sKRSIkcnUrIeM/WnF6WBrqOad3VlXhQcnNSmDEQDDO7rzTDMGCAQ/Ke6NnIq3PdBIlAAJx360yTAkthHKehHXrirFgzm4zgbDk4qvd3hkldozg5xjFWtMuQkW+QKxbgZHal1GU9RuYDdoPuuegPtVa/sjLCJISSRw3qff3qr4kh+1Bmiwrg7lxWbpWuNs+z3HEq8Bj1PtSb1HYklBjUq0eNx/Ksi/iz86Yx7dq3ZbuORWWReW7jpWNcuqs2BgfpSZSMlWCtl+lYPiLUTMwhU/u0PP1q9rF2kKkRn5j0Fcjdzcnn8aWw0itdTZB5rIupfrVm6m4NZcjFnPPFQ2WkRsdzZpMGnY5ox7UihtOWgjjGKO1AEq80H1pgPOMU5zxQFyBxzTGHFSmmEdRQAiDKj6U7FPVflFO20CI8UgHNSlaTb70BcjxzQaeRnvTSKAG0U4+9GKAG1o2LDbis8Ves88ZoQmb1g1dVpuNq+4rkbPsa6XSp1VlDcirRmdfpyGQdcj2rq9O09pGj255GDXOaIqs6srZB9q9I0VUJQKuTjPNWlcls57VNElC+dGMOOcf4Vc0u9LwiOYYYfKfrXeLaLcoEfCkjnua4fxDZHTL3zFB2HqQOvvQ1yiTvoWcrjALHbyMnpWPqkgaaNMnJ61bjmDAHPHrWeT5+pFv4UFSyloaVgAFLdW6AntU0KOqSlkG8dMnr9KgiUrg9hzjNTxupxuBwOtMRf0+TbKCNw2Dk5rDvoz9rkcY2sxOB9a0DcsFJC47jFZ1yTuJByOuPeh7DRksnmXZB5VaW9tEljHRW7ED+dX9OtzIHcDJZv0pJ0KSMM4APOaVgbMvStUutJulWQl4ScFScj6iui1G8N2gMb4HUDpj61kywJKucjkd6hule2WOWM/Lj8qd7C3JRII2/fFuDwo7mnNfM3zlgBjjAqncOs0CugwVOMZ6Vlyzt69+KLjSNgTPK3XB/nXL61Kv2x9g+ZeCR61cN4Y+XYL71zl3c+ZNI+fvMTSvoMurrE0PDBZB/tVVv9fuHiKBIkX2HNZc82M1m3U/v+FJMY28uC7MzHJPvWPczZz3qS5nyTzWVcTFiQPzqWUkMnk3HGagAxTuaMUihD0oxS0Y9aAExQRinHpSY9qBid6Q0/FIQaBDD0FIehqQDikK5zQMsGBgMGlER96+pfDv7OMDhJvEWpsCcEwWq9PYsf6V3Ft8CfA0Me06fPKf70k7E0N9kZpPsfEPkmmsmK+2r34CeCLiMiO1u4GxwyTnj8DXmvjL9nC7tonn8MagLwDn7POAr/gehqea26B3W6PmsrzTSMVua9oWoaJfSWep2s1tcIcNHIuDWM64qk76oaaepEaSnn6U00FXGkVctO1VKuWo4FAma9qcVt2T4IrBtyeK1rNjkVRDPRfCcoAHsa9N0W5RWErNxxkAV4tod4beYDPymu90rWBFjzAG6Y46VpFktXPUEvREhc/6wjLAdB+dYfiS6t7qzld22KBkc1hTat5il3fC92Y9axbm7k1WcRJkQKeT6+9OUtLCUSrHevESqgMvbitDSGd2c7TvJzXS6PYxSRCJ4I8Y4DYrRPh4Kd1vgEdF7/h61KixuVtDCSJsHqOOe9T7MRmNx8vetCe1kt4v30eRnggVXgMcr/eHTJBNOwrlTc0qtlfvcVVvY2jjHHbgVtXHlopOV2kVUjja7uUyo8tTk0rDDSbF44BcSDaoHGaz9UcO7DAOW5Ga6i8uAYyhAEaDAHSufvbd5MO2MsOg7VTVkStTJXgZbGO+PXtSSkNC8f94ZGakdAcoDjnqetOu7Xy7MzuwTavJJ4+lSM5UagLdpIpUIxxn3rJur35j5Y49TRqMwkuJWHRjxWVK/YmkWhZ52kJ3GqcsuKSaQDvVC4mwSKQx1xNwayLufP0p1zPwcGse5mLsQDxSvYa1C4mLHC1XxnvSgc0uKkobindqU5pMUDE7UY6Uvelx6UAJ0pMU8Cl2mgLjMUu30HNSqmamjgJpiuVljJqZIGOcCtK3sGcjAP5V0GnaE8oA2E+9InmPviiiig0CiiigDkfiP4F0zxxoslpfRol2ozBdBfmjb69x7V8G67YHTtTurR2DPBK0ZZehIOM0UVC0noZtWkZbUwnHNFFalCZ5q7bEYFFFIDStcE+1a9oQAPWiiqM0bdp0FbtpcOoA4OPWiigpmnaLJezLG8n59BXUafDHaqiouW6kmiimiWbMFsshZpSSifO2OCa1NP1mRJsTrujLbUVf4cDiiitYk2OjublZ4HDxh9iHJbqTXKwwwtPII025U8HmiinJEoint1OBk804FYUAUdeKKKlLUZTu52DHkkg45rLN46Oy4DDGcEcUUUhonLwRnzZoiz9SAcCuQ8Q6zPqLtCv7uBDjaO+PWiih6IEcnctjIrOkfjvRRWZfUpzycHrWXPJ1oooAybyY7sVTzRRUvcuIoIpciiigYZApSQDRRS6AwOM0ZHvRRTEPXk1MkYJoopiZct7cNitvTtORyM4oooJeh2+geHI5mXLLXr3hDwJbzhSzp+VFFOKM5to//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This anteroposterior view shows a healing 5th metacarpal neck fracture. Callous formation can be see along the radial side of the distal metacarpal (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin Burroughs, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_29_37342=[""].join("\n");
var outline_f36_29_37342=null;
var title_f36_29_37343="Optic pit";
var content_f36_29_37343=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F80394&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F80394&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Optic pit",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 274px; height: 371px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the oval gray excavation nasally (arrows). This nasal location is unusual because most optic pits are inferior or temporal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Karl C Golnik, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_29_37343=[""].join("\n");
var outline_f36_29_37343=null;
